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The ability to deliver a prescribed radiation dose to a patient within a narrow tolerance affects 
the success or failure of a radiotherapy treatment. The presence of high-density implants in a 
patient can compromise the accuracy of this delivered dose if the radiation beam passes 
through it. For this reason, it is currently recommended to plan treatments such that the 
beams do not pass through high-Z materials to reach the intended target. For some treatments 
however, this practice is not always possible and often results in less than ideal dose 
distributions being delivered to avoid uncertainties. If a better understanding of dose 
distributions in the vicinity of high-density implants could be achieved, more accurate 
radiotherapy treatments could be delivered with more confidence, resulting in improved 
patient outcomes. As such, this work aims to quantify the effects of a specific clinical implant 
by developing a methodology whereby the dosimetric effects of high-density materials can be 
accurately and efficiently predicted during treatment planning. 
 
The initial investigation aims at quantifying the dosimetric effects of the temporary tissue 
expander, which is often present during postmastectomy radiotherapy treatments. 
Conventional dosimetry techniques were used to evaluate photon and electron beam dose 
distributions for a variety of different phantoms and beam geometries. Using EBT2 
radiochromic film, it was shown that the magnetic disk present in a tissue expander causes a 
dose reduction of approximately 20% in a photon tangent treatment and 56% in electron 
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boost fields immediately downstream of the implant. The effects of the silicon elastomer 
were also much more apparent in an electron beam than a photon beam. This investigation 
demonstrates that each component of the tissue expander attenuates the radiation beam to 
different degrees, and highlights the limitations of current dosimetry methodologies for 
efficiently evaluating 3D dose distributions surrounding high-density implants.  
 
Based on the results in the initial investigation, the importance of an accurately modelled 
high-density implant in the treatment planning system was demonstrated. The work that 
followed used Monte Carlo simulations to evaluate the Pinnacle Treatment Planning 
System’s dose calculations for the high-density magnetic valve in the temporary tissue 
expander. The work demonstrated the importance of an extended CT ramp to accommodate 
for high-Z materials since an override correction was required for accurate dose calculations. 
While this work demonstrated the potential for an accurate theoretical understanding of 3D 
radiotherapy dose distributions in complex mediums, there remains a need to verify these 
dose distributions via direct measurement.  Radiosensitive gels were considered to be a 
potential candidate in the measurement of complex 3D dose distributions surrounding high-
density implants. 
 
The subsequent investigation examined potential sources of uncertainty when radiosensitive 
gels are used in dose distribution measurements for implants suspended in the dosimeter. This 
piece of work established the degradation in image quality, and subsequent dose evaluation 
inaccuracies, that are encountered when an optical-CT system reconstructs an image slice of a 
gel dosimeter containing an opaque implant, and evaluated the feasibility of a simple 
correction method to improve the accuracy of radiotherapy dose distribution measurements 
under these circumstances. This correction was shown to significantly improve dose 
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evaluation accuracy close to the suspended implant. With careful placement of the implant 
within the gel sample, and use of the linear interpolation method described in this section of 
work, it was demonstrated that there is the potential for more accurate optical CT imaging of 
gels with immersed high-density implants. 
 
Improvements to the accuracy of dose information close to the surface of implants suspended 
in 3D gel dosimeters were achieved in the subsequent investigation. A methodology was 
developed which allows for Fricke gel dosimeters to be used in conjunction with optical-CT 
scanning techniques for dose distribution measurements surrounding high-density materials. 
Custom 3D printed moulds were used to set cavities in Fricke gel phantoms to allow for the 
suspension of high density implants in various geometries. This allowed for the high-density 
metal implant to be suspended during irradiation, and removed during imaging, 
circumventing the production of artifacts induced by missing ray-sum data. Dose 
measurements within 1 mm of the cavity were subject to slight dosimetric inaccuracies due to 
diffusion of reactants across the interface or increased oxygen exposure resulting in a varied 
sensitivity. Despite this, dosimetric accuracy was shown for gel dose profiles at distances 
greater than 1 mm from the interface. Artefacts were all effectively removed using this 
technique enabling the broader and more accurate use of optical-CT for the imaging of gels 
containing opaque objects. 
 
This developed methodology for 3D Fricke gel dosimeters and optical-CT scanning protocols 
was then able to be applied to the verification of high dose rate brachytherapy treatments. In 
this investigation, a multi-catheter brachytherapy gel phantom was irradiated and the 
measured doses from optical CT scanning were compared to those calculated by the 
treatment planning system. The removal of the stainless steel needles and subsequent 
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backfilling of these cavities with optically matched fluid prior to imaging enabled accurate 
optical-CT scanning of the gel. Results showed agreement within 1% between measured and 
calculated doses to within 1 mm of each catheter. Additionally, the ease with which these 
Fricke gel phantoms were manufactured and used to verify multicatheter dose distributions 
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1.1 Research Problem  
Cancer is the leading cause of death in Australia, and it is estimated that 130,466 new cases 
of cancer will be diagnosed in 2016 [1]. About one-fifth of the total disease burden in 
Australia is caused by cancer [2], costing the Australian community about $4.5 billion in 
direct health system costs annually [3]. Subsequently, extensive research and resources have 
been devoted to develop techniques to fight cancer. Today, radiation therapy is one of the 
most important methods of cancer treatment alongside chemotherapy and surgical resection. 
Radiotherapy is most commonly achieved by an external beam of X-rays or electrons using a 
linear accelerator or by implanting radioactive seeds directly into the tumour.  
The success or failure of radiation therapy treatments is largely dependent on the 
ability to deliver the prescribed dose to the patient within a narrow tolerance. However, the 
human body consists of many components that vary in density which have been shown to 
cause complications in treatment planning and hence delivery. These can include naturally 
occurring internal inhomogeneities, as well as man-made biomaterials such as implants and 
prostheses. While these may be necessary for the survival or quality of life of radiotherapy 
patients, they also have the potential to seriously compromise the accuracy of radiotherapy 
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treatment planning, and delivery.	 Consequently, treatment outcomes can be dramatically 
different from what is intended. 
Statistics from the Australian Institute of Health and Welfare show that 80% of 
Australians have a dental filling [4] which may place constraints on head and neck 
radiotherapy treatments. Furthermore, between 3% and 5% of men in the key age range for 
prostate cancer alone have had at least one total hip replacement and the female patient hip 
replacement rate is approximately 1.5 times higher [5] with implications for ovarian and 
cervical radiotherapy. The demographics of patients receiving other implants and prostheses 
are very similar to those receiving radiotherapy, resulting in a large overlap. And with greater 
access to healthcare and an ageing population, the number of these patients is increasing 
annually.  
These high-density implants and prostheses present complications during computed 
tomography (CT) imaging [6]. They are known to cause local increases in dose due to lateral-
scatter and backscatter of radiation in addition to depletion of downstream dose due to 
attenuation. The size of the dose perturbation due to the high-density media depends on the 
design and composition of the implant and characteristics of the radiation. Correcting the 
issues associated with implants in radiotherapy will enable clinics to deliver conventional 
treatments with increased confidence to these patients.  
 
1.2 Aims of this Project 
This research aims to establish a methodology whereby the effects of high-density implants 
could be quantified accurately and efficiently. By better understanding the impact of high-
density materials on radiotherapy dose distributions, more accurate treatments can be 
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delivered with increased confidence, resulting in improved patient outcomes. Specific 
objectives can be summarised as follows: (1) establish the dose perturbation effects of a 
specific high-density clinical implant using conventional dosimetry techniques, (2) quantify 
the uncertainties involved in treatment planning for patients with high-density implants and 
the subsequent need for a suitable 3D dosimetry system for treatment verification, and (3) 
develop and validate a methodology for using 3D gels and optical scanning techniques for 
dose distribution measurements in the vicinity of high-density implants. 
 
1.3 Thesis Structure and Overview 
The structure of this thesis is as follows; the first 2 chapters provide the motivation and 
background to the problem, after which Chapters 3 and 4 further investigate the effect of 
metallic implants on radiotherapy dose distributions and planning by examining the specific 
case of a temporary tissue expander port and density overrides in treatment planning systems. 
The project then moves on, in Chapters 5 and 6, to develop a methodology for measuring 
dose distributions around embedded implants with gel dosimetry, by investigating irradiation 
geometries and issues with optical readout of opaque objects, and Chapter 7 shows that this 
methodology can be expanded beyond the issue of implants to the similar problem of gel 
dosimetry in the presence of brachytherapy needles. The chapters themselves are described 
below: 
§ Chapter 1 presents a brief introduction to the research problem, describes the major aims 
of this work, and details the structure of each section in this thesis.  
§ Chapter 2 of the thesis provides a literature review and general background information 
for this project. An introduction to radiotherapy and the effects of high-density materials 
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is given as well as a description of the strengths and limitations of various dose 
verification methods and imaging systems. 
§ Chapter 3 uses conventional 2D dosimetry techniques to investigate dose distributions 
around the Temporary Tissue Expander in breast cancer radiotherapy treatments. This 
chapter establishes the effects that this high-density implant can have on	 electron and 
photon beam dose distributions. 
§ Chapter 4 expands on the work in the previous chapter by demonstrating the potential for 
inaccurate density assignment and underestimation of dosimetric effects, by conventional 
treatment planning systems when high-density materials are present. This was achieved 
by comparing experimental dose distribution data with equivalent Monte Carlo (MC) 
simulations, and Treatment Planning Calculations for the Temporary Tissue Expander. 
§ Chapter 5 aims to understand and improve the degradation in image quality that results 
when 3D gel dosimeters are used in conjunction with optical-CT scanning to evaluate 
dose distributions surrounding opaque objects. A pre-reconstruction correction was 
shown to improve dose evaluation accuracy in the vicinity of high-density implants. 
§ Chapter 6 describes a developed methodology for using Fricke gel dosimeters for dose 
distribution measurements surrounding high-density implants which completely 
circumvents artifact production that was established in the previous chapter. Artefacts 
were all effectively removed using the outlined methodology enabling the broader and 
more accurate use of optical-CT for the imaging of gels containing opaque objects. 
§ Chapter 7 incorporates the methodology outlined in the previous chapter to demonstrate 
the potential for 3D Fricke gel phantoms in the verification of high dose rate 
brachytherapy treatments.  
§ Chapter 8 summarizes the results of the thesis, describes the key outcomes, and concludes 







Background and Literature Review 
 
The following chapter provides an overview of the fundamental physics concerning 
radiotherapy and radiation dosimetry. Section 2.2 describes the issues associated with 
radiotherapy treatment planning and delivery in the presence of high-density implants. 
Section 2.3 discusses various dose verification methods with a focus on 3D gel dosimetry and 
quantitative imaging systems. This discussion highlights the limitations of conventional 2D 
dosimetry systems and the suitability of 3D gel dosimeters for investigating distributions in 
the vicinity of high-density materials. 
 
2.1 Radiation Therapy 
Radiation therapy is the treatment of cancer with ionizing radiation to damage the DNA 
within the malignant cells, making them unable to divide and grow.  The ability to deliver the 
prescribed dose to the patient within a narrow tolerance affects the success of a radiation 
therapy treatment. This prescribed dose of radiation depends on a number of factors including 
the size, stage, and location of the tumour.  
 
Patient imaging improves target volume delineation and can ensure that the delivered 
radiation is targeted precisely to maximize the dose to the tumour, while minimizing the dose 
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to the nearby healthy tissue. This can be accomplished via magnetic resonance imaging 
(MRI), positron emission tomography (PET), or most commonly via X-ray computed 
tomography (CT). Complications may arise if surrounding healthy tissues or vital organs are 
exposed to more than the prescribed dose. Thus, verifying this dose to improve the accuracy 
of dose delivery to the patient is of paramount importance during radiotherapy treatments. 
 
2.1.1 External beam radiotherapy 
One of the primary sources of ionising radiation used in external beam radiotherapy (EBRT) 
is the medical linear accelerator (linac) [7]. The linac is an instrument that uses high-
frequency electromagnetic waves to accelerate electrons to high energies in a waveguide. 
Depending on the configuration of the treatment head, the ionizing radiation produced by the 
linac can have either an electromagnetic form, such as a high-energy photon, or a particulate 
form, such as an electron. If electron beam therapy is required, the electrons will be incident 
on a scattering foil, which is designed to spread the beam as well as producing uniform 
electron fluence across the treatment field. Electron beam applicators or cones are then used 
to collimate the beam, and are attached to the treatment unit head. If photons are required, the 
electron beam will be incident upon a target of high-density material where the 
bremsstrahlung production will be anisotropic and largely forward projected. For either 
treatment modality, shaping of the beam is an important way to minimise the absorbed dose 
in healthy tissue.  
 
Conventional collimator jaws are used for shaping a rectangular treatment field. These 
jaws use a lead or tungsten alloy to limit the radiation transmission and are designed such that 
the edge of the jaw is aligned to the angle of beam divergence. However, since the treatment 
volume is usually not rectangular, additional shaping of the beam is often required. This can 
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be achieved by using a multi-leaf collimator (MLC) system, which has movable leaves that 
can limit transmission of the radiation beam. By moving and controlling a large number of 
narrow, individual leaves, almost any desired field shape can be generated, thus more 
complex treatments can be planned to conform more precisely to target volumes. Dosimetric 
inaccuracies in the delivered dose of these complex treatments can be detrimental to a 
patient’s health. Significant changes in tumour control probability and normal tissue 
complication probability can occur if the delivered dose deviates by as little as 5% from the 
planned dose [8]. Verifying that these dose distribution calculated by the treatment planning 
systems match the delivered dose is fundamental in assuring the accuracy of treatments.  
 
2.1.2 Brachytherapy 
Brachytherapy is a form of radiotherapy which involves placing radioactive sources inside, or 
next to, tumours in the body. It is frequently used as the treatment for prostate [9], cervix 
[10], and breast tumours [11], and can also be effective in treating many other sites [12]. 
Because of its steep dose gradient, brachytherapy has the advantage over EBRT in reducing 
the dose outside the target volume, thereby limiting any radiation induced side effects or 
complications. High dose rate (HDR) brachytherapy employs a single radioactive source to 
deliver high doses to a small volume, in a short amount of time. The source is moved step by 
step through needles that have been implanted in the patient. In order to achieve the 
prescribed dose distribution, the source is moved within the needles to discrete positions for 
specific dwell times by a remote afterloader device.  
 
There are many steps involved in a HDR brachytherapy treatment, starting from 
implant positioning to imaging, treatment planning and dose delivery [13]. This makes the 
radiation doses delivered to the patient susceptible to various inaccuracies	 and may not 
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accurately match the planned doses. Possible inaccuracies and errors might be due to 
needles/catheters shifting in the time lapse between imaging and treatment, artefacts in the 
CT images, failure in the digital reconstruction of the needles during planning, and 
limitations of the dose calculations algorithm [14]. The importance of independent dosimetric 
verification prior to the treatment is highlighted in the AERB safety code as well as in the 
guidelines of other international regulatory agencies [15]. A pre-treatment dosimetric 
verification would ensure that the correct source is being used; that the source data has not 
been modified and correct activity, treatment date, and decay are used; and that any bugs in 
the planning software have not affected the dose calculation [16]. However, errors induced by 
shifting needles/catheters between imaging and treatment, as well as the uncertainties 
involved in the digital reconstruction of the needles during planning will not be corrected 
with pre-treatment dose verification. Nevertheless, when dealing with such high doses, pre-
treatment verification becomes an important aspect of patient-specific quality assurance. 
 
Furthermore, increasingly sophisticated brachytherapy techniques continue to develop 
parallel to advancements in 3D imaging, by the development of modern afterloaders and by 
the constantly increasing speed and capacity of computers [12]. With this increase in 
treatment complexity, the need for verification of the treatment planning calculations by 
direct measurement becomes even more important. However, there are some issues that make 
establishing a simple, fast, and accurate dose verification methodology for HDR 
brachytherapy treatments difficult, as it would require a dosimetry system with an equally 
high resolution, flat energy response, and high sensitivity, water equivalence, dose linearity, 




2.2 Radiation Physics and Inhomogeneities 
The presence of high-density implants in a patient results in attenuation of the radiation 
through the inhomogeneity as well as local perturbations known as interface effects. For 
megavoltage energies, attenuation via the Compton effect is dependent on electron density, 
while the interface effects can be attributed to pair production within the high-density 
material itself.  This can compromise the dosimetric accuracy of a treatment if the radiation 
beam passes through it. It is currently recommended to avoid treatments where the beams 
pass through the high-density media before reaching the target volume [18], but sometimes 
this isn’t possible or often it results in a sub-optimal treatment being delivered to avoid 
uncertainties. If the dosimetric effects could be predicted during treatment planning, the 
accurate delivery of radiotherapy treatments would be ensured, resulting in improved patient 
outcomes. Typically, high-density materials compromise the quality of radiotherapy 
treatments via well known, but often unconsidered mechanisms such as dose perturbation 
effects during radiation delivery, as well as inaccurate density assignments and the 
production of artefacts during treatment planning. Most modern calculation algorithms 
implemented in three dimension planning systems are the pencil beam (PB) and the collapsed 
cone (CC). The CC algorithm implements various approximations in the physics of radiation 
transport, which reduces the calculation time to levels that are acceptable for clinical practice. 
While PB algorithm is very fast, its limitations are highlighted in dealing with heterogeneous 
media [7-8].  
 
2.2.1 Dose Perturbation  
The presence of high-density implants in a patient can result in the attenuation of the 
delivered dose through the inhomogeneity as well as perturbations known as interface effects 
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[19-23]. The size of the dose perturbations due to the high-Z media depends on a number of 
factors including the design and composition of the implant and characteristics of the 
radiation.  
 
A report published by the AAPM Task Group 63 [18] highlights issues arising from 
the presence of metal devices during radiotherapy, and provides recommendations regarding 
treatment planning and delivery. In the report, dose distribution studies related to various hip 
implants illustrated the effects that high-Z materials can have on radiotherapy treatments. 
Such effects have also been investigated for aneurism clips [24-26], spinal fixation rods [27, 
28], and dental implants [23, 29, 30], but conflicting reports on the dosimetric impact of 
temporary tissue expanders (TTEs) suggests that further investigation is required.  
 
TTEs are used in post-mastectomy breast reconstructions for selected breast cancer 
patients, and since radiotherapy treatment is usually started 4 to 8 weeks after the mastectomy 
surgery, some patients undergo radiotherapy with the implant present. These TTEs are made 
of a membrane composed of silicone elastomer, a chemically inert and mechanically robust 
material. The silicone membrane is periodically filled with a saline solution until the desired 
expansion is reached. A magnetic disk allows the position of the implant’s valve to be 
determined inside the patient’s body. This high-density disk has the potential to seriously 
compromise the accuracy of radiotherapy treatment planning dose calculations, and hence 
delivery [31].  
 
Several studies have been performed, examining the effects of tissue expanders on 
radiotherapy dosimetry. Moni et. al. [32] completed measurements around the magnetic valve 
of a McGhan 133 (Inamed/Allergan) tissue expander using film and thermoluminescent 
41 
	
dosimeters (TLD) for a 6 MV photon beam. These measurements were designed to 
investigate increased dose around the port due to scatter from the high density metal and 
found that there was no increased dose in the region of the metallic port. However, the results 
showed a decrease in the dose measured directly under the metallic port of around 25% in a 
region of 1.7 to 3.7 cm downstream. Damast et. al. [33] also investigated the effect of a 
McGhan Style 133 tissue expander in a radiotherapy treatment using film and TLDs. Similar 
underdosing was identified but the authors concluded that this was not clinically significant 
due to the small volume of tissue underdosed. Thompson and Morgan’s [34] diode 
measurements described an 11% dose enhancement in a region of 5 mm around the valve and 
an underdosing of 10% to the radiation target when tangential photon beams were used.  
 
Chatzigiannis et. al. [35] performed Monte Carlo simulations using CT images of a 
patient implanted with a McGhan Style 133 tissue expander. The magnet of the valve was 
simulated as being composed by Neodymium-iron-boron. Attenuation of 6–13% was found 
through all the area in the shadow of the magnetic valve and a dose enhancement around 10% 
was found near the metallic structure.  
Notably, all of these studies [32-35] examined the effects of only one type of tissue 
expander (McGhan Inamed/Allergan) on photon-beam dose distributions. Their findings 
showed conflicting reports on backscatter measurements and differing magnitudes of dose 
reduction. Since breast-cancer patients with tissue expanders continue to be treated with both 
photon and electron-beam radiotherapy, there is an obvious need for a thorough examination 
of the effects of these implants on the doses delivered by both tangential photon fields and 




A recently published study by Srivastava et. al. [36] compared ion chamber 
measurements with treatment planning system (TPS) calculations and concluded that high-Z 
materials should be avoided due to their poor modelling in TPS algorithms. This failure to 
accurately calculate dose distributions could be attributed to incorrect CT density 
assignments for high-Z materials [37]. Irrespective of TPS inaccuracies, the avoidance of a 
high-density port is not a practical option in post-mastectomy radiotherapy and may result in 
sub-optimal treatments being delivered to the patient. 
 
2.2.2 Inaccurate Density Assignment 
In addition to high density metallic implants causing dose perturbations of radiotherapy 
beams, they also pose a challenge in modern CT based treatment planning for radiation 
therapy due to CT artefacts [38-40]. For example, sections of transverse slices through two 
patients’ CT images are shown in Figure 2.1 which illustrates this degradation in image 
quality. Light streaks and dark shadows can appear in the reconstructed patient data causing 
tissue to have a higher or lower apparent density. These artefacts can also alter the apparent 
volume and shape of the high-density structure, further limiting the ability to plan an accurate 
patient treatment [37]. 
 




These artefacts surrounding metal implants in CT images are induced by a number of 
mechanisms including the absorption or scattering of X-rays, as well as beam hardening 
effects. Beam hardening occurs since the lower energy component of a polychromatic x-ray 
spectrum is more easily attenuated when traveling through a medium of high density or 
atomic number. Additionally, the increased scatter caused by the high-Z material can cause 
photons to be detected at points which would otherwise have very few photons due to the 
implant blocking the incident radiation. Thus, beam hardening and scatter can both cause 
dark streaks along the lines of greatest attenuation. In addition, the filtered back projection 
(FBP) method, which is currently employed in the reconstruction of x-ray CT data, does not 
provide a mechanism to deal with the effects of beam hardening and scatter, subsequently 
producing the bright streaks seen in Figure 2.1. 
 
Artefacts induced by high-density materials can reduce the accuracy of the 
classification of electron densities in a patient’s tissues which are of significant importance 
for accurate treatment planning calculations. Contemporary 3D radiotherapy treatment 
planning relies upon the use of 3D electron density maps derived from computed tomography 
(CT) scans of patient anatomy, to evaluate the effects of that anatomy on radiation dose 
distributions. Production of these electron density maps requires that the CT numbers 
(Hounsfield units, HU) that quantify the attenuation of the X-ray beam by the patient’s 
anatomy must be reliably converted into electron densities, using a stable calibration 
relationship. However, CT scanners used in radiotherapy treatment planning are generally not 
calibrated to identify, or even approximate, electron densities of high-density materials [42]. 
These materials are known to affect CT image quality, causing artefacts and potentially 
affecting dose calculations [43-45]. Additionally, CT scanners and some commercial 
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treatment planning systems have a high-density cut-off, above which all electron densities are 
assumed to have the same value [46]. 
 
The Pinnacle TPS relates the Hounsfield Units (HU) of a CT dataset to relative 
density to water via linear interpolation between two points of a CT-density ramp. The 
standard CT-ramp has a maximum radiodensity to ensure that while all human tissues 
densities can be automatically looked up by the TPS, it cannot automatically assign densities 
higher than bone to the CT artifacts [47]. This is an effective way to reduce the dosimetric 
error caused by the bright artifacts. For instance, uncorrected artefacts from a bilateral hip 
replacement have been shown to produce dose prediction errors of up 25 % in nearby tissues 
[48]. However, an extended CT ramp is required to assign densities to metallic implants to 
ensure accurate dose distribution calculations. 
 
Current treatment planning systems allow the user to contour regions affected by 
artefacts and apply density over-rides, so that the artificial densities of the affected regions 
can be corrected. The use of CT overrides to correct apparent tissue densities can minimise 
errors in dose calculations for beams that are not transmitted through the metal implant [49]. 
In cases where radiation beams necessarily pass through implants, reliable assessments of the 
radiodensities of the implant materials are needed. Errors in this density assignment can cause 
significant errors in doses predicted by the treatment planning system. For example, TPS 
calculations surrounding spinal rods have been shown to overestimate the downstream dose 
by almost 6% without the application of a suitable density override [47]. Similarly, plans 
using an extended CT table reduced the impact of dental artefacts on head and neck treatment 
planning to acceptable levels [50]. While the value of density over-rides for treated tissue is 
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well established, the necessity and magnitude of density over rides for a variety of implants 
requires further investigation. 
 
2.3 Radiation Dosimetry 
A radiation dosimeter is a device, instrument or system that is capable of reading the 
absorbed dose deposited in its sensitive volume by ionizing radiation. The main objective in 
radiotherapy is to ensure the accurate delivery of dose to a tumor and at the same time, 
minimize the dose to healthy tissue. Effectively treating certain types of cancer points 
requires an accuracy of approximately ±5% in dose delivery [8, 51]. This is a very stringent 
requirement, considering the uncertainties in equipment calibration, treatment planning, and 
patient setup. Utilising dosimeters in order to minimise the variation of dose delivery in 
radiation therapy is of significant importance. Additionally, there are a number of difficulties 
associated with dosimetry in the vicinity of high-density materials making some detectors 
more suitable than others. Hence, the characteristics of each detector, including size, 
reproducibility, linearity, and dependence on photon energy, dose rate, or direction, should be 
thoroughly investigated before use. 
 
2.3.1  Conventional Dose Verification Methods 
There are a variety of different dosimeters that can be employed to verify dose distributions 
for radiotherapy treatments. Based on the desired characteristics outlined above, each system 
has its own benefits, and potential drawbacks. 
 
Ion chambers are one of the more prevalent dosimeters for external beam radiotherapy 
measurements [52, 53]. While this detector has a high accuracy and practicality, it is limited 
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to point dose measurements in one dimension. While ionisation chambers have been used for 
measuring dose distributions surrounding high-density materials [28, 54], because of its 
relatively large size, this detector can suffer from poor spatial resolution making it unsuitable 
for the measurement of high-dose gradients. Semiconductor diodes can be more suited to 
resolving steep dose gradients given their relatively smaller active volume. While these 
detectors are also limited to point dose measurements in one dimension, arrays of diodes can 
be used to achieve pseudo 2D and 3D dose distribution maps [55-58]. These solid state 
detectors do however suffer from radiation induced damage thus requiring periodic 
calibration. 
 
Capturing actual 2D distributions can be achieved using radiochromic film dosimeters 
by relating the absorbed dose to the optical density of the film. With careful use, and proper 
calibration and analysis, accurate absolute dose information can be achieved [59, 60]. Since it 
is relatively tissue equivalent, exhibits high sensitivity, and high spatial resolution, 
radiochromic film is a popular choice for dosimetry surrounding high-density implants [24, 
29, 31-33, 61-63]. It has also been shown that pseudo-3D dose distributions are possible, 
however this process is time consuming and subject to large measurement uncertainties 
during film processing [64, 65].  
Evidently, the measurement of complex 3D dose distributions surrounding high-
density implants is a difficult task that requires an efficient and reproducible dosimetry 
method capable of high-resolution, low-uncertainty dose measurements. Monte Carlo (MC) 
modelling has been shown to provide an accurate theoretical understanding of 3D 
radiotherapy dose distributions in complex mediums. These simulations employ random 
numbers to sample outcomes of stochastic processes. This allows the simulation of particle 
transport by sampling from probability density functions describing particle interaction 
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outcomes. MC simulations represent the most accurate method for patient dose calculations 
in radiotherapy [66]. The development of faster computational systems and the advancements 
of faster Monte Carlo simulation algorithms offer a unique opportunity for the use of Monte 
Carlo calculations in the clinical environment of radiation oncology.  
 
There are many different applications of the technique used in medical physics 
including investigations of dose distributions in the vicinity of high-density implants [35, 67-
71]. Subsequently, there are various MC-based codes available for calculating the radiation 
dose. The Electron Gamma Shower system (EGS) is one of the most widely used MC codes 
for simulating radiation transport, with special emphasis on transport involving electrons and 
photons. This code is useful in simulating electrons and photons with energies in excess of a 
few keV up to several hundred GeV, and has been widely benchmarked [45, 72-75]. While 
advances in Monte Carlo modelling have allowed for a more accurate theoretical 
understanding of 3D radiotherapy dose distributions in complex mediums, there remains a 
need to verify these dose distributions via direct measurement.  Radiosensitive 3D gels are 
considered to be a potential candidate in the pursuit of this requirement. 
 
2.3.2 3D Gel Dosimetry 
The determination of absorbed dose in three dimensions is fundamental to clinical 
environments, but as outlined above, few methods exist by which 3D measurements can be 
made easily and accurately. Gel dosimeters are inherently 3D, do not perturb the radiation 
beam, and have the capacity to measure complex dose distributions [76]. Radiosensitive gels 
operate based on chemical changes that occur in the dosimeter after exposure to ionizing 
radiation. Contemporary gel dosimetry involves extracting this dose information using a 
variety of different imaging methods including magnetic resonance imaging (MRI), X-ray 
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CT, ultrasound, and optical computed tomography (optical-CT). The imaging modality 
depends on the properties of the gel dosimeter in use. As outlined previously, various 
dosimetry methods have been used to establish the effects of high-density implants in 
radiotherapy; however, gel dosimeters offer the advantage of being able to place the implant 
in-situ to match the conditions of the placement in the patient, and then record radiation dose 
distributions in three-dimensions (3D). There are a variety of different gels available, but two 
of the main formulations are Polymer Gels and Fricke Gels.  
 
2.3.2.1 Polymer Gels 
One of the most commonly used 3D dosimeters are polymer gels [77-79], which are 
manufactured from radiation sensitive chemicals that polymerise upon irradiation. This 
polymerisation is induced by free radicals that are released during radiolysis of the water 
within the gel. The magnitude of polymerisation is proportional to the absorbed dose. One of 
the more widely used polymer gels is the PAGAT formulation which consists of acrylamide 
and N,N’-methylene-bisacrylamide crosslinker dissolved in an aqueous gelatin matrix. The 
PAGAT polymer gel has been investigated by several research groups and is recognised as 
having many characteristics that are suitable for 3D dosimetry such as spatial stability, 
reliability, and reproducibility [80]. The radiation initiates changes to numerous physical 
properties of the PAGAT gel, which can be imaged using MRI [81], optical scanning [82], 
ultrasound [83], and x-ray computed tomography [84]. 
 
However, this gel suffers from some major complications during manufacturing. Free 
radicals that are produced during water radiolysis can be scavenged by oxygen, subsequently 
inhibiting the polymerisation reaction [36-38]. This restriction necessitates the use of the 
oxygen scavenger tetrakis hydroxymethyl phosphonium chloride (THPC) to remove oxygen 
49 
	
that is initially dissolved in the gel [84]. Additionally, since a number of the chemicals used 
during manufacturing are known carcinogens and neurotoxins, the ability to routinely use 
these gels in a clinical radiotherapy environment is significantly limited. 
 
Despite these limitations, a number of studies have used polymer gel dosimeters to 
examine dose distributions surrounding high-density materials [25, 85, 86]. In these works, 
artefacts caused by the presence of metals during imaging reduce the accuracy of dosimetric 
evaluation. Often, additional reference measurements were made of un-irradiated gels to 
quantify the effect of artefacts caused by the high-density material. While this would improve 
dosimetric accuracy, it cannot be assumed to remove or correct these imaging issues 
completely [87, 88]. Polymer gels have also been used to obtain 3D dose distributions of a 
HDR brachytherapy source for single catheter irradiations [89, 90].	 However, for multi-
catheter treatments, the ability to accurately evaluate dose distributions can once again be 
severely limited by artefacts induced by the presence of high-density materials during 
imaging. 
 
2.3.2.2 Fricke Gels 
Unlike polymer gels, Fricke gels do not suffer from oxygen sensitivity. They incorporate the 
well-known Fricke solution into a gel matrix allowing for 3D dosimetric measurements. 
Irradiation of the Fricke solutions causes ferrous ions (Fe2+) to be converted to ferric ions 
(Fe3+) in an amount proportional to the absorbed dose of radiation. This causes a change in 
the paramagnetic properties of the gel permitting MRI imaging. The use of chelating agents 
such as xylenol orange induces colour changes that permit optical-CT scanning. The 
permissible time between irradiation and imaging of a Fricke gel dosimeter is however 




Progress has been made in reducing diffusion rates either by replacing gelatine with 
different gelling agents [92] or through the use of functionalised polymers [93]. Additionally, 
since optical scanning methods can achieve high-resolution dose mapping in a matter of 
minutes, the effects of ferric ion diffusion can be effectively nullified. Since the Fricke gel 
formulation has been shown to be approximately radiologically water equivalent for electron 
and photon beams, easy to prepare, and give reproducible results, it becomes very attractive 
for 3D dosimetry [94]. Additionally, the Fricke gel formulation exhibits energy independence 
(>30 keV) and dose linearity (0.1-30 Gy) [95] making it a suitable dosimeter for establishing 
the effects of high-density implants on patient dosimetry.  
 
Not only are Fricke gels suitable for high resolution dose measurements of high dose 
gradients in external beam radiotherapy [96], but they have also been used in the verification 
of brachytherapy treatments [17]. Studies have used Fricke gel-layer dosimetry [97] as well 
as Fricke gel dosimetric catheters (FGDC) [98] to measure 2D in vivo dose distributions 
produced by a 192Ir brachytherapy source. These works have demonstrated the potential for 
dose verification of HDR brachytherapy distributions using the Fricke gel formulation as it 
offers a number of advantages over other dosimetry methods. 
 
2.3.2.3 Quantitative Imaging 
Parallel to research into gel formulations, there has also been a focus on developments in 
imaging techniques for dose distributions in gel dosimeters. Extracting dose information from 
gel dosimeters can be accomplished using a variety of different methods. The preferred 
imaging modality (MRI, optical-CT, X-ray CT, or ultrasound) is chosen based on the type of 




Historically, MRI has been the most common method of extracting dose information 
from gel phantoms [81, 99-101]. Radiation induced chemical changes in the paramagnetic 
properties of a gel allow for dose maps to be acquired by a commercial MRI scanner. There 
are however, practical and technical difficulties limiting the ability to use this imaging 
modality for dosimetry purposes. The accuracy of dose distributions measured by MRI can be 
affected by changes in the temperature of the gel during scanning [102]. Furthermore, eddy 
currents and magnetic field inhomogeneities have been shown to cause geometrical 
distortions affecting the spatial accuracy of dose distributions. Scanning orientation and field 
of view size have also been shown to affect the apparent dose response of the gel [103]. Since 
access to MRI machines is limited and expensive, the routine use of MRI for gel dosimetry in 
a clinical environment becomes difficult. Additionally, the readout of gel dosimeters can be 
limited by ferromagnetic implants, which can pose hazards in MRI environments. Because of 
this, alternate methods of extracting dose information from gel dosimeters which are not 
subject to these limitations can be used. 
 
Many studies have examined the feasibility of X-ray CT and ultrasound based CT to 
study dose response in polymer gel dosimeters [83, 104]. Due to changes in the measurement 
of velocity and attenuation in the irradiated gel, ultrasound has been shown to have the 
potential to evaluate dose distributions. Additionally, changes in the physical density of 
polymer gels after irradiation permit the use of X-ray CT for dose evaluation. However, both 
of these imaging techniques yield low signal to noise and can introduce significant metal 
streaking artefacts in the evaluation of gels containing high-density materials. Furthermore, 
they are limited to polymer gels, as various other gel dosimeters present no clear physical 




Optical-CT offers an alternative method for evaluating dose distributions which 
improves upon the deficiencies of previously outlined imaging modalities. Unlike MRI 
machines, for which the availability can be limited, optical-CT systems are suitable in a 
clinical environment because of it low operating costs and efficient scanning times [105]. Its 
function is based on the attenuation of a monochromatic light source through the gel 
measured by a light sensitive photo-diode [106]. For polymer gels, this attenuation is a result 
of the increased optical scatter caused by radiation induced polymerisation. The use of 
optical-CT scanning for Fricke gels is also possible since radiation causes changes in visible 
absorption of the dosimeter. Speed and accuracy are the two major considerations which 
drive the design of optical CT scanners for gel dosimetry. As such, there are two groups of 
scanners that have been built.  
 
The first generation scanner is based on a single laser source coupled to a single 
photodiode detector. The source and detector scan across the gel while the dosimeter is 
rotated using a stepper-motor thus creating projection data at different angles. To ensure 
accurate scanning, the gel phantom must be immersed in a medium with a refractive index 
matching that of the gel [107]. Image slices are then reconstructed using the filtered back 
projection algorithm. Multiple slices are obtained by adjusting the height of the laser source, 
allowing the creation of a full 3D dose distribution. The main disadvantage of this first 
generation of optical-CT is the slow scanning speed which can be problematic when dealing 
with gels with poor spatial stability [76]. The second generation addresses this deficiency by 
using an incoherent broad light source and a CCD camera. Optical CT scanners that use 
broad light sources are able to map the dose distribution from an irradiated gel dosimeter with 
a CCD camera in a matter of minutes [108]. This is particularly beneficial when using the 
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Fricke gel formulation, as the diffusion of spatial information stored in the dosimeter requires 
efficient scanning times [52]. 
 
 However, serious artefacts caused by missing ray-sum data induced by opaque 
implants can be produced when using an imaging system, with FBP based image 
reconstruction. The FBP method, which is currently employed in x-ray CT, MRI, and optical-
CT systems, does not provide a mechanism to deal with incomplete ray-sum data caused by 
metallic or opaque implants [109].  Such is the case, when measuring the impact of implants 
on radiotherapy beams [25, 76, 110] or other imbedded objects such as scintillators [111] or 
brachytherapy [112] sources. A number of different reconstruction methods to reduce metal 
artefacts in x-ray CT have been proposed [73, 113] showing mixed results. However, these 
correction methods are less accessible for optical-CT systems and the commercially available 
reconstruction software makes it preferable to apply any corrections prior to image 
reconstruction via the FBP algorithm. Alternatively, rather than attempting to suppress, or 
minimise the influence of these artefacts, investigations into new gel dosimetry methods 













Dosimetric impact of the temporary tissue expander 
 
3.1 Introduction 
The work in this chapter aims to address objective (1) by quantifying the dosimetric effects of 
the Mentor temporary tissue expander - an implant that is often present during 
postmastectomy radiotherapy treatments. This implant, shown in Fig. 3.1, is made up of a 
silicone elastomer membrane which houses a neodymium magnet fixed underneath a titanium 
valve. Since effective postmastectomy treatments cannot be planned without the beam 
passing through the high-Z material, it is important to establish the effects that this implant 
has on dose distributions. While there are a number of studies which have investigated the 
effects of a McGhan Style 133 TTE on photon-beam dose distributions [32-35], few studies 
exist which have quantified the effects of a Mentor TTE on photon and electron beam dose 
distributions. 
 
Therefore, in the present study different phantom and beam geometries are explored to 
provide a more comprehensive understanding of the effects of this tissue expander in post-
mastectomy radiotherapy. Conventional dosimetry techniques were used to evaluate the 
perturbation effects of this specific clinical implant, as well as highlight the limitations of 




     




3.2.1 Planar Lung Phantom 
In this study, dose distribution measurements around a Mentor TTE were performed using 
EBT2 radiochromic film (International Specialty Products, Wayne, USA). The implant was 
partially filled with 250 cm3 of a 0.9% saline solution, and then placed atop a planar phantom 
composed of an arrangement of water and lung equivalent materials (Standard Imaging, 
Middleton, USA), illustrated in Figure 3.2. Additionally, a 1.5 cm layer of bolus was placed 
over the top of the implant such that the phantom set-up models the subcutaneous 
implantation of the expander in a patient. Pieces of film were then positioned 0 cm and 2 cm 
downstream of the implant as well as one piece of film immediately upstream to measure any 
backscatter caused by the high-Z material. The TTE was irradiated isocentrically (98.5cm 
SSD) using a 15x15 cm2 field of 6 MV photons, as well as 12 MeV electrons, at incidences 
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perpendicular to the heterogeneity. These irradiations were performed on a Varian iX Clinac 
(Varian® Medical System, Palo Alto, CA). 
 
 
Figure 3.2 Illustration of the planar phantom arrangement, TTE placement, and film locations (thick 
black lines) during photon and electron beam irradiations (bolus not shown). 
 
3.2.2 CIRS Thorax Phantom 
Measurements were also made using a CIRS IMRT thorax phantom, this time with the TTE 
filled with 400 cm3 of the saline solution. Once again, a 15x15 cm2, 6 MV photon field was 
delivered at an incidence perpendicular to the heterogeneity (gantry angle of 340o). These 
irradiations were performed on a Varian iX Clinac (Varian® Medical System, Palo Alto, 
CA). Once more, film was placed above and below the implant. An additional piece was 
placed running parallel to the incident beam between slices of the thorax phantom. Fig. 3.3 
demonstrates the alignment of our experimental conditions to a clinical case with a CT slice 
of the thorax /TTE phantom and overlying bolus compared to an image slice of a patient with 
the subcutaneous implantation of a tissue expander. 
    
Beam Direction 
1 cm solid water 
1 cm solid water 
6 cm foam (lung equivalent) 
2 cm solid water 
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Figure 3.3 (a) CT slice of the thorax phantom indicating beam angles and TTE placement. (b) Image 
slice of a patient with implanted tissue expander. 
 
Finally, a beam arrangement was adopted from a clinical plan where photon tangents were 
modulated using a forward-planned IMRT (field-in-field) technique [114, 115]. This involved 
delivering segmented, tangent photon fields (dynamic wedged fields) at angles of 70o and 
250o with film placed immediately upstream and downstream of the implant. The technique 
has been shown to provide more homogeneous dose distributions in the planning target 
volume (PTV) and reduced doses in the organs at risk (OAR) [116].  
 
3.2.3 Film Evaluation 
The film was scanned and evaluated using an Epson flatbed scanner (V750) as per the 
protocol outlined in Kairn et. al. [117] and Aland et. al. [59] which minimised the effects of 
film heterogeneity and scanner output variations. The dose reduction values presented in this 
work were calculated as the percentage difference between the average doses outside the 
shadow of the magnet, relative to the doses in the region directly under the magnet. 







3.3 Results and Discussion 
Fig. 3.4 shows the dose profile of the implant at two different depths, downstream of the 
breast implant in the planar phantom for a 6 MV photon beam at 0o gantry. At 0 cm, in the 
region directly below the magnetic valve, the dose is reduced by as much as 15 ± 3 %. This 
figure also reports a 12 ± 2 % dose reduction at 2 cm below the bottom edge of the implant. 
No backscatter dose enhancements were reported in the radiochromic film and were therefore 











   
	 	
Figure 3.4 Dose profiles of a 6 MV photon beam at different depths downstream of the implant. Inset 
indicates beam direction, film locations (thick black lines), and profile positions. 
 
The qualitative data, displayed in Fig. 3.5 (a), clearly illustrates the perturbation effects the 
high-density magnetic port, as well as the silicone elastomer in the 12 MeV electron beam at 
different depths. Increased bremsstrahlung around the edges of the implant is also visible. 





Figure 3.5 (a) Images of scanned EBT2 film showing attenuation of the 12 MeV electron beam 
through the temporary tissue expander at 0 cm (left) and 2 cm (right) downstream. (b) Corresponding 
central-axis profile plots at different depths downstream of the tissue expander. Inset indicates beam 
direction and film locations (thick black lines). 
 
Fig. 3.5 (b) shows the dose profile of the TTE in a 12 MeV electron boost field at two 
distances downstream of the implant in a planar phantom. At 0 cm depth, a substantial dose 






reduction of approximately 56 ± 6 % is reported compared to the dose recorded outside the 
magnet’s field shadow. It should be noted that the at the location of the profile taken outside 
of the magnet’s shadow there is a slight difference of overlaying tissue thickness compared to 
that taken in the magnet’s shadow due to the curvature of the implant surface, however the 
difference to the dose profile is negligible in comparison to the effect of the metallic port.  
Given that boost fields are typically delivered as per this experimental setup, electron 
treatments of post-mastectomy patients with TTEs would be compromised by the presence of 
this high-Z material. The effects of the silicon elastomer are also much more apparent in the 
electron beam than the photon beam.  
 
Photon beam measurements in the CIRS IMRT thorax phantom illustrate the perturbation 
effects of each component of the implant and are shown in Fig. 3.6. Moving averages have 






                   
Figure 3.6 6 MV photon depth dose profiles in the CIRS thorax phantom downstream of different 






From Fig. 3.6, it was determined that profiles downstream of the silicone elastomer/saline 
interface averaged doses around 8% lower when compared to profiles taken outside the 
implant’s shadow. Differences for profiles taken under the titanium base, titanium ring and 
neodymium magnet were approximately 12%, 15% and 19% respectively. These results 
agree with what is expected when considering the scaled depth of each implant component 
and its density. It should be noted that there are slight differences in depth caused by the 
curved shape of the implant; however, this would have no effect on the order of which 
components attenuate the most. This highlights the importance for an accurately modelled 
high-density implant in the treatment planning system. 
 
Photon tangent fields were also delivered to the thorax phantom and the results in Fig. 3.7 
illustrate a combined dose reduction of 20% caused by the high-density magnet in both 
treatment directions, calculated once again using the percentage difference between the 
average dose values outside the shadow of the magnet, relative to the dose value in the region 
directly downstream of the magnetic port.  Given that post-mastectomy treatments are 
typically delivered as per this experimental setup, the impact of the TTE on photon dose 
distributions would be significant if it’s not accurately accounted for in planning. The insets 
indicate in Fig. 3.7 indicate the approximate profile locations as well as pictographically 





                          
Figure 3.7 Dose profiles of a 6 MV photon treatment for two beam tangents at gantry angles of 70o 
and 250o. The data has been smoothed with the application of a moving average filter. Insets indicate 







This chapter demonstrated that the magnetic disk present in a tissue expander causes an 
average dose reduction of approximately 20% in photon tangent fields and 56% in electron 
boost fields immediately downstream of the implant. The silicone elastomer shell of the 
Mentor implant has also been shown to reduce the dose to a section of the target volume by 
as much as 8% in a 6 MV photon field, which in turn reduces the probability of tumour 
control. Evidently, each component of the TTE attenuates the radiation beam to different 
degrees with the most significant dose perturbation occurring due to attenuation through the 
magnetic disk. This highlights the importance for an accurately modelled implant in the 
treatment planning system for post-mastectomy patients, specifically for materials which 
have a high-density or high atomic number. The densities of these metallic structures must be 
precisely identified to provide accurate treatment planning dose calculations for 
postmastectomy radiotherapy patients. The work from this chapter has been published in 














Results in the previous chapter clearly emphasise the importance of accurately modelled 
high-density implants in the treatment planning system for post-mastectomy patients. This 
chapter focusses on objective (2) by aiming to demonstrate the uncertainties involved in 
treatment planning for patients with high-density implants and the subsequent need for a 
suitable 3D dosimetry system for treatment verification. The accuracy of the Pinnacle TPS 
and its limitations in accurately predicting the dosimetric effects of high density materials 
was evaluated with comparisons to experimental measurements and MC simulations. 
 
To accomplish this, a 6 MV Monte Carlo (MC) model was validated and used to investigate 
the dosimetric effects of the internal magnetic port (IMP) extracted from the TTE. A 
validated MC model can provide accurate 3D dose distributions, and a single beam study in 
water is appropriate to demonstrate the attenuation effects of the high-density materials. The 
difference in dose calculations between using a standard CT–ramp and an extended CT–ramp 
in the Pinnacle TPS was investigated to provide useful data on when, and to what degree, a 
manual density override to the implant is required. The accuracy of the Pinnacle TPS and its 
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limitations in handling high density materials was evaluated by comparisons with the MC 
simulations. This chapter aims to provide data and recommendations on when manual density 
override to the high-Z materials in the TTE is warranted. 
 
4.2 Methods 
4.2.1 Experimental Measurements 
In order to perform dose distribution measurements of the high-density valve in a water tank, 
the implant was cut up and the internal magnetic port (IMP) was removed from its silicone 
housing. A cross section of this IMP is shown in Fig. 4.1 illustrates that is made up of a 
titanium valve and base, and a neodymium magnet used for locating the valve under the 
patients’ skin [110]. Depth dose and profile measurements under the IMP of the Mentor TTE 
were conducted with a Roos ionization chamber (Type 34001) and a water tank in 6 MV 
photon fields (Figure 4.1). These measurements were repeated in water with no IMP present 
for comparison. A field size of 15 × 15 cm2 was used for the photon beams. The linac was 
continuously delivering dose at a rate of 600MU/min while the dosimeters recorded a series 
of cross-profiles. Photon profile depths were at 20, 50 and 100 mm for the 6 MV beam. A CT 
scan of the suspended TTE in a water tank was also taken in order to complete subsequent 





Figure 4.1 Photo of the excised internal magnetic port submerged in the water tank. Inset illustrates 
cross section of IMP. 
 
4.2.2 Treatment Planning Calculations 
CT data of the IMP suspended in a water tank was acquired using Siemens CT scanner 
(Siemens AG Medical Solutions, Waukesha, Germany) before being imported into the 
Pinnacle3 V9.8 (Philips Radiation Oncology Systems, Fitchburg, WI) treatment planning 
system where dose profiles were calculated with the collapsed-cone convolution (CC) 
algorithm. The standard CT conversion table of the TPS was linearly extrapolated to an 
arbitrary value to account for the increased density of the magnetic port used in this dose 
calculation. The voxel size of TPS phantom dose calculation grid was 1 × 1 × 1 mm3 which is 
the standard grid size in Pinnacle TPS. Originally, contours were completed for both the 
neodymium magnet as well as the titanium port; however, preliminary results indicated a 
significant overestimation of the dose attenuation caused by the titanium valve as shown in 
Fig. 4.2 (a-b). In the dose profiles acquired with the ionisation chamber, the dosimetric 
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effects of the titanium valve were insignificant compared to the effects calculated by the 
treatment planning system. This was attributed to the contouring being limited to 1 mm 
resolution despite the actual thickness of the titanium being 0.3 mm. For this reason, the 
perturbation effects of the titanium were not considered in this investigation.  
 
Doses were then calculated using Pinnacle TPS for densities of 1.8 or 7.4 g/cm3 
assigned to the neodymium magnet. These numbers were chosen, because the real physical 
density of neodymium-boron-iron rare earth magnets is between 7.2 - 7.6 g/cm3 [118], while 
using the standard CT ramp would result in an automatically assigned a density of 1.8 g/cm3 
by the TPS. The accuracy of the TPS calculations was investigated by comparing its 
calculations with the MC results and chamber measurements.	 
                
Figure 4.2 Treatment planning isodoses for contours of the (a) neodymium magnet, titanium base, 





4.2.3 Monte Carlo Simulations 
The MC code used in this investigation was BEAMnrc [27, 35]. MC phase space files were 
generated for 6 MV photons with field size of 15 x 15 cm2 delivered by a Varian 21iX 
Clinac. Roos ionization chamber (Type 34001) measurements were used to benchmark the 
MC beam model and are shown in Fig. 4.3. CTCREATE was then used to generate an 
EGSnrc compatible phantom, based on the CT data used in the TPS. For Monte Carlo 
calculations, the atomic number and relative masses of each element used in the temporary 
tissue expander’s metal valve were entered into the PEGS4 data file. These values matched 
the physical densities used in the TPS to allow for comparison. The magnet of the valve was 
simulated as being composed of Neodymium-iron-boron. Doses were normalised to the dose 
at 20 mm depth and the statistical uncertainty of the MC results was less than 1%.  
 
4.3 Results and Discussion 
To validate the MC model, the calculated dose profile was compared to doses measured by an 
ion chamber and the results are shown in Fig 4.3. The model was found to be sufficient given 
that the variation between experimentally determined, and MC simulated results was less 
than 2% at depths of 20, 50 and 100 mm. There were slight deviations observed at the edges 
of the field, but these were attributed to potential volume averaging effects of the ion 




Figure 4.3 Monte Carlo simulated, Pinnacle calculated and Ion Chamber measured cross profile for 
field size of 15 × 15 cm2 at depths of 20, 50, and 100 mm. The statistical uncertainty of MC averaged 
less than 1%. 
 
Figure 4.4 Monte Carlo simulated, Pinnacle calculated and Ion Chamber measured cross profiles 
under the magnetic valve for field size of 15 × 15 cm2 at depths of 20, 50 and 100 mm. The 
neodymium magnet was corrected with a density override of 1.8 g/cm3. The statistical uncertainty of 
MC averaged less than 1%. 
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Figure 4.4 and 4.5 show the results of the dose perturbation caused by the neodymium 
magnet when the standard and extended CT- ramps are used. These highlight the 
underestimation of the dose reduction downstream of the implant, when the physical density 
of the magnet is not accurately described in the TPS. 
          
Figure 4.5 Monte Carlo simulated, Pinnacle calculated and Ion Chamber measured cross profiles 
under the magnetic valve for field size of 15 × 15 cm2 at depths of 20, 50 and 100 mm. The 
neodymium magnet was corrected with a density override of 7.4 g/cm3. The statistical uncertainty of 
MC averaged less than 1%. 
 
Table 4.1 describes the percentage difference between downstream doses measured by the 
Roos ionisation chamber with those calculated by the Pinnacle treatment planning system, 
and Monte Carlo simulations. When the standard CT-ramp is used, both the MC and TPS 
calculations show an underestimation in the dose depletion downstream of the implant by 4-
6% across the various depth tested. Conversely, applying density override corrections from 
an extended CT ramp results in a slight overestimation in the dose depletion with the 
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difference reducing to between 0.5 and 1.5 % for both Monte Carlo and treatment planning 
calculations.  
 
These results indicate that using the extended CT-ramp reduced the difference between 
experimental and calculated dose perturbations values to within experimental uncertainty. 
However, it is important to note that the application of an extended CT-ramp can cause 
significant dose calculation inaccuracies in the tissue surrounding implants as a result of 
artefacts generated during x-ray CT scanning. Therefore, it is important that these artefacts 
are contoured separately and the inaccurate density assignments are overridden with 
appropriate tissue density values. 
 
Depth (mm) 
Percentage difference from measured downstream dose 
Monte Carlo Simulation Treatment Planning Calculation 
CT Threshold Physical Density CT Threshold Physical Density 
20 6 % - 0.5 % 5.5 % - 0.5 % 
50 5.5 % - 1.5 % 5.5 % - 1.5 % 
100 4.5 % - 0.5 % 4 % - 0.5 % 
Table 4.1 The percentage difference between downstream doses measured by the Roos 
ionisation chamber and doses calculated by the Pinnacle treatment planning system, and 
Monte Carlo simulations for densities of 1.8 g/cm3 (CT threshold), and 7.4 g/cm3 (physical 
density). These are the differences from dose profiles taken with no implant present. 
 
4.4  Conclusions 
Metal artifacts caused by the neodymium magnet can introduce dosimetric errors in 
postmastectomy radiotherapy treatment planning. While using a CT–ramp with a maximum 
density cut-off may reduce the dosimetric error from the artifacts, there is the potential for an 
underestimation of the dose perturbation caused by the high-density material. Since this 
implant has the potential to be in the beam path, an accurate understanding of the dose 
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perturbation effects is of significant importance. Therefore, it is recommended to extend the 
CT-ramp in the TPS if possible, and manually override the density of neodymium magnet to 
7.4 g/cm3 to ensure a more accurate dose calculation downstream of the implant. However, if 
the CT conversion table is extended, artefacts caused by the high-density implant must be 
contoured separately to ensure that the TPS does not automatically assign erroneously high 
densities to tissue equivalent materials. 
 
The use of MC simulations and TPS calculations provides an accurate theoretical 
understanding of the dosimetric effects of the magnetic disk extracted from the Mentor TTE. 
However, this process required the validation of the three dimensional MC and TPS results 
via the acquisition of cross profile dose measurements using an inherently 1D dosimeter. 
Despite this process showing sufficient accuracy, it is both indirect and inefficient thus 
demonstrating the need for an accurate and efficient 3D dosimetry system in the vicinity of 
















While the results in the previous chapter demonstrated the potential for an accurate 
theoretical understanding of 3D radiotherapy dose distributions in complex mediums, there 
remains a need to verify these dose distributions via direct measurement.  Film measurements 
do provide an accurate result and a better understanding of the dose perturbations caused by 
implants; however, its use as a dosimeter in the vicinity of high-density materials in general is 
limited by the 2D nature of the dosimeter as well as the inherent uncertainties in film 
irradiation and processing.  Radiosensitive gels are considered to be a potential candidate in 
the measurement of complex 3D dose distributions surrounding high-density implants. 
However, there are certain difficulties limiting the ability to achieve accurate dose 
information from 3D gel dosimeters which contain suspended high-density implants. 
 
When an opaque object is present within the gel dosimeter, such as the case when measuring 
the impact of implants on radiotherapy beams, artefacts generated during imaging limit the 
accuracy of dose evaluation.  Fig 5.1 shows reconstructed image slices of gel phantoms with 
suspended high-density implants, demonstrating the artefacts that can be induced by opacities 
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during optical-CT imaging. In this section of work, the problems associated with optical-CT 
scanning of a 3D gel dosimeter with embedded high-density implants are highlighted, and the 
feasibility of a simple pre-reconstruction correction method to improve the accuracy of 
radiotherapy dose distribution measurements under these circumstances is evaluated. 
 
Figure 5.1 Reconstructed image slices of gel phantoms containing a suspended high-density 




MATLAB (version 8.4.0.150421, R2014b) was used to generate a series of virtual irradiated 
gel phantoms along with their synthetic projections and reconstructed data sets. This 
simulated work permitted the exclusion of noise influences and light scattering effects, which 
allowed effects of missing projections on the image quality of an optical-CT system to be 
specifically evaluated. Fig. 5.2 illustrates how each virtual phantom was forward-projected 
using the RADON function to produce sinograms, which emulate the result that would be 
obtained via optical-CT scanning. Removing a defined range from the projection data in each 
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sinogram models the effects of having a completely attenuating object present in the 
phantom. Sinograms were then reconstructed using the IRADON function for projections 
sampled at 0.25o intervals, using cubic interpolation, and the Hann window for frequency 
domain filtering. 
 
A variety of virtual phantoms were created to investigate the potential for 3D gel dose 
distribution measurements for phantoms containing both water equivalent and high density 
implants. Here we simulated a simple 6 MV photon treatment of a circular gel phantom with 
an opaque object. The effect of the radiation beam on gel opacity was modelled as a wide, 
linear region of elevated pixel values passing through the simulated gel cylinder. The falloff 
of radiation dose (and gel opacity) with depth was modelled as a simple exponential 
attenuation – a decrease in the pixel values in the region from the top to the bottom of the 
simulated gel cylinder. Image slices were reconstructed with 1 mm, and 0.25 mm pixel size to 
investigate the dependence of artifacts on pixel resolution. To highlight the problems 
associated with dose measurements close to high-Z interfaces, an implant that reduces 











The feasibility of a simple pre-reconstruction correction method to improve the accuracy of 
gel dosimetry dose distribution measurements was also evaluated. The missing ray-sum data 
was amended by linearly interpolating between the data points immediately adjacent to the 
object for each angular projection. Fig. 5.2 (a) shows an example of a virtual gel phantom 
with its forward projected sinogram and back projected reconstruction. Fig. 5.2 (b) shows a 
comparable set of simulations for a similar gel phantom that contains a dense object as 
demonstrated by the depleted signal in the central axis of the sinogram. An example of the 
application of this method is shown in Fig. 5.2 (c). 
 
 
Figure 5.2 Simulated dose distributions of a circular phantom with a square-field irradiation. Each 
row of images depicts the original virtual phantom, followed by its forward projected sinogram (with 
a corresponding profile), and back projected reconstructions. (a) Sinogram with a complete set of 
projection data, (b) Sinogram with missing projection data, and (c) Sinogram with missing projection 





5.2.2 Experimental Measurements 
A PAGAT polymer gel dosimeter was prepared as per the recipe recommended by Venning 
et. al.  and Khoei et. al. [80, 81]. When the preparation of the final polymer gel solution was 
completed, it was transferred into two 7cm diameter, cylindrical containers one of which 
contained a 1.5cm diameter circular obstruction. The containers were allowed to set for 24 
hours by storage in a refrigerator. Irradiations were performed at 100 SSD with a 6 MV, 3×3 
cm2 photon beam from an Elekta Precise linac. 3D dose distributions were read out 24 hours 
after irradiation, using the MGS Research IQScan optical CT scanner. The data was 
reconstructed to match results from simulated work using the FBP algorithm with cubic 
interpolation, and the Hann window for frequency domain filtering. The method of linear 
interpolation of missing projection data was also applied to this experimental work. 
 
5.3 Results and Discussion 
Fig. 5.3 shows the results of a simulated photon radiotherapy treatment beam delivered to a 
circular phantom containing an opaque object. The virtual phantom has been reconstructed 
with 1 mm resolution in Fig. 5.3 (b) and its corresponding profile plot is shown in Fig. 5.4. 
These results demonstrate that when an image slice contains an obstruction, the missing ray-
sum data induces obvious ring artifacts. Fig. 5.3 (c) shows the same virtual phantom with 
reduced artifacts after a 0.25 mm pixel size reconstruction. Therefore, to suppress these 
artifacts, and reduce the noise observed in the profile plot, the number of angular projections 
set during image acquisition should be increased, thus increasing the resolution, to reduce 




               
Figure 5.3 (a) Simulated 6 MV photon treatment of a circular gel phantom with opaque, water 
equivalent obstruction. (b) Image slices have been reconstructed with 1 mm pixels, (c) 0.25 mm 
pixels, and (d) by linear interpolation of the missing projection data. 
The central axis profile plots in Fig. 5.4 show the difference between the simulated dose 
distribution and the dose distribution after reconstruction with the FBP algorithm. These 
profiles show a significant dose offset from the true distribution as much as 20 mm away 
from the obstruction. Clearly, calculating the dose in image slices that contain an obstruction 
is susceptible to serious inaccuracies since the FBP algorithm is unable to deal with missing 
ray-sum data. This makes it difficult to evaluate any local radiation perturbations or interface 







The dose distribution of data replaced by linear interpolation is a closer match to the true dose 
distribution as shown in Fig. 5.4. An upstream dose (17 mm profile position) error of 27% 
relative to the true dose has been reduced to 6% after linearly interpolating the missing ray-
sum data. Similarly, the downstream dose (35 mm profile position) error relative to the true 
dose has been reduced from 14% to 5%. Using the interpolation correction, the dose 
distribution displayed in Fig. 5.4 has been accurately reconstructed to within approximately 
15 mm of the opacity. 
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Figure 5.4 Central axis profile plot of reconstructed 6MV treatment. Approximate profile positions 
are displayed in Figure 5.2. These profiles are not intended to present estimations of the dose inside 




Figure 5.5 Off axis profile plot of reconstructed treatment plan data. Approximate profile positions 
are displayed in Figure 5.2. 
 
The off-axis profile plots in Fig. 5.5 also illustrate the improved accuracy of dose evaluation 
when the missing ray-sum data is linearly interpolated. In the central regions beside the 
obstruction (22 mm profile position), error reduction from 14% to 5% relative to the true dose 
is observed. Moving away from the implant, more significant error reductions are observed; 
at a profile position of 5 mm, the error is reduced from 15% to 2%.  
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Figure 5.6 (a) Simulated 6 MV photon treatment plan of a circular gel phantom with opaque, high-
density obstruction which reduces the dose. (b) Image slices have been reconstructed for incomplete 
sets of projections, and (c) and for projection data that has been linearly interpolated. 
 
The simulated results of photon treatment plans of a circular gel phantom with a high-density 
obstruction are presented in Fig. 5.6. A downstream dose depletion caused by a high-density 
implant has been simulated; however, the increased doses caused by lateral-scatter and 
backscatter were not considered in these simulations. For high-density implant dosimetry, 
characterising the downstream dose depletion is of paramount importance. These specific 
conditions were simulated to evaluate the potential for 3D gel dose distribution measurements 
in the vicinity of high-density implants. Corresponding central axis profile plots in Fig. 5.7 
shows the difference between the true dose distribution and the dose distribution after 
reconstruction with the FBP algorithm.  




Figure 5.7 Central axis profile plot of reconstructed treatment plan data. Approximate profile 
positions are displayed in Figure 5.5. These profiles are not intended to present estimations of the 
dose inside the obstruction, but rather the doses in the region of the interface. 
 
The uncorrected data once again shows significant artifacts surrounding the obstruction. 
Relative to the true dose, errors of 24% upstream (17 mm profile position) and 9% 
downstream (35 mm profile position) are present for the data sets that have been 
reconstructed using FBP. Applying the linear interpolation reduces the upstream error to 9% 
and the downstream error to 5%. Once again, using the interpolation correction, the dose 
distribution in Fig. 5.7 has been significantly improved to be accurately resolvable within 
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Figure 5.8 Sinogram and corresponding image reconstructions for a simple square 6MV photon field 
with an approximately water equivalent obstruction. (a) Image has been reconstructed from sinogram 
with incomplete ray-sum data, and (b) and for data that has been linearly interpolated 
 
Fig. 5.8 (a) displays a raw sinogram with missing ray-sum data obtained from an optical scan 
of a gel phantom irradiated with a simple 6 MV square photon field. The reconstructed image 
illustrates that this missing ray-sum data causes serious artifacts, which present themselves as 
light spots upstream and downstream of the obstruction. Radial streaking artifacts are also 
present in Fig. 5.8 (a) and are highlighted in the corresponding profile plot in Fig. 5.9. 
 
Fig. 5.8 (b) shows the result of replacing missing ray-sum data through linear interpolation, 
with corresponding percentage depth-dose (PDD) profile plots in Fig. 5.9. Interpolation of the 
missing data has successfully minimised the radial streaking artifacts and smoothed the off-























Figure 5.9 Uncorrected vs. interpolated off axis PDD profile plot of experimental dose distribution 
data. Approximate profile positions are displayed in Figure 5.7. 
 
5.4 Conclusions 
Use of the FPB algorithm to reconstruct optical CT image slices containing opaque objects 
can lead to substantial inaccuracies if the effects of missing projections are not taken into 
account. However, the measurement uncertainties can be significantly reduced if a simple 
linear interpolation method is used to correct the sinograms affected by the opaque object. 
The application of this simple linear interpolation correction prior to reconstruction via the 
FBP algorithm has been shown to significantly improve dose evaluation accuracy to within 
approximately 15 mm of the opacity. While these residual uncertainties are substantial, and 
limit the usability of this method when measurements within a few millimetres of the edge of 
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the implant are particularly desired, they nonetheless represent a dramatic improvement in the 
achievable measurement accuracy of optical CT readout in the presence of opaque objects.  
 
Importantly, optical CT slices that are acquired at points adjacent to an opaque object, which 
contain no part of the opaque object, are not affected by the missing projections issue 
discussed in this work. Accurate gel dosimetry measurements at regions within a few 
millimetres of the surface of the implant may therefore be achieved by careful placement of 
the implant within the gel, so that the regions of particular dosimetric interest are located 
above and below the implant, where the opacity of the implant does not corrupt the FBP 
result. 
 
A number of different reconstruction methods to reduce metal artefacts in x-ray CT have 
been investigated [73, 113] showing mixed results. However, these correction methods are 
less accessible for optical-CT systems and the commercially available reconstruction 
software makes it preferable to apply any corrections prior to image reconstruction via the 
FBP algorithm. Therefore, the linear interpolation method described in this chapter has the 
potential to enable the broader and more accurate use of optical CT for the imaging of gels 
containing opaque objects. Applying this correction to gel dosimeters which contain an 
irremovable obstruction during imaging, dramatically improves the accuracy of dosimetric 
evaluation. However, if implants could be suspended in gels during irradiation and removed 
during imaging, further improvements could be made to accuracy of dose information much 
closer to the implant.  
 











Dose distribution measurements in the vicinity of 
high density implants using 3D gel dosimeters 
 
6.1 Introduction 
The results in Chapter 5 demonstrated a dramatic improvement in the achievable 
measurement accuracy of optical CT readout in the presence of opaque objects. However, if 
accurate gel dosimetry measurements at regions within a few millimetres of the surface of an 
implant are desired, further improvements are necessary. In this chapter, objective (3) was 
addressed which involved aiming to develop and validate a methodology for using 3D gels 
and optical scanning techniques for dose distribution measurements in the vicinity of high-
density implants. Initially, the PAGAT gel formulation was investigated for this section of 
work due to its advantageous spatial stability (See Appendix A). However, given its 
susceptibility to oxygen contamination as well as the lengthier manufacturing time, 
corrections to polymer gels containing suspended implants are essentially limited to the linear 
interpolation methods described in the previous chapter. In this chapter, the Fricke gel 
formulation was utilised since the problem of diffusion could be negated by adopting 




In this work, cavities are set in Fricke gel phantoms allowing for high-density metal 
implants to be suspended during irradiation, and removed during optical-CT imaging. The 
developed methodology allows for gel dosimeters to be used in conjunction with optical-CT 
scanning techniques for dose distribution measurements surrounding high-density implants. 
 
6.2 Methods 
6.2.1 Gel Phantom Manufacturing 
In order to create a cavity in the gel so that the implant could be suspended during irradiation, 
then removed during imaging, moulds were generated via 3D printing. In this study, the 
Fricke Xylenol (FX) Gel dosimeters were composed of: gelatin from porcine skin of 300 
Bloom strength, sulfuric acid, ferrous sulfate (FS), xylenol orange (XO), Glyoxal, and Milli-
Q water [119]. Modifications to the original recipe included: increasing the gelatin 
concentration to 12.5% by weight, and reducing XO and FS concentrations to 0.1 mM to 
avoid volume limits given large container size. The gel formulation was mixed with a 
magnetic stirrer whilst the heat was maintained at approximately 45oC.  
 
The implant used for this work is a metal valve extracted from the Mentor Temporary Tissue 
Expander (Mentor, Magna-Site disk, Santa Clara, CA, USA). This implant contains a high-
density neodymium magnet (7.4g/cm3) that is sometimes present during post-mastectomy 
radiotherapy treatments [120]. Fig. 6.1 shows two 3D models that were custom designed in 
SketchUp Make 8 (Trimble Navigation Limited, Sunnyvale, California, USA). The models 
were then exported as stereolithography files and printed on a MakerBot Replicator 2 
(MakerBot, Brooklyn, NY) using polyactic acid (PLA) filament. The designs were created to 




These moulds were used to set a cavity in two 800 ml Fricke gel phantoms (9.6 cm diameter, 
11 cm height) allowing for the suspension of a metal valve extracted from a Mentor 
Temporary Tissue Expander in two different orientations. The custom designs were printed 
using a 40% infill volume to increase the weight, 0.1 mm resolution to ensure an accurately 
printed geometry, and triple layered walling to prevent seepage of gel inside the mould and 
thus ensure a clean and consistent removal. A single vent hole was incorporated through the 
centre of each mould to prevent vacuum effects, and allow airflow during removal. 
Additionally, the mould was coated with a cellophane tape due to its hydrophobic properties 






Figure 6.1 3D printed models used to set a cavity in Fricke gel phantoms allowing for the suspension 
of a high-density implant in two different orientations. 
 
Once the moulds were removed, the cavity that remained was filled with water to maintain 
tissue equivalency during irradiation. For Optical-CT scanning, pre- and post-irradiation, 
Glycerol was combined with an identical FX solution without the gelling agent to ensure 
refractive index matching in the cavity (~10 volume parts 0.1 mM FX solution to ~3 parts 
Glycerol). This is important since there is the potential for missing ray-sum data during 
scanning, in this instance caused by total internal reflection at critical angles if the fluid in the 
cavity is not matched optically. 
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6.2.2 Gel Irradiation 
 
Figure 6.2 Diagram showing irradiation geometry for (a) 6MV photon beam, and (b) 12MeV 
electrons. 
 
The first irradiation was achieved with a 6MV,	5×5 cm2 photon field from a Varian iX Clinac 
(Varian Medical Systems, Palo Alto, USA) at a gantry angle of 270o and is shown in Fig. 6.2 
(a). This was done in order to investigate the ability for this system to resolve the perturbed 
dose distal to the high-Z material, as well as increased dose lateral to the inhomogeneity due 
to the increased lateral scatter. Additionally, the metal valve was irradiated isocentrically 
using a 6×6cm2 field of 12 MeV electrons at an incidence perpendicular to the heterogeneity 
as shown in Fig. 6.2 (b). This was done to investigate the potential for electron boost field 
dosimetry surrounding the implant [120].  
 
6.2.3 Gel Scanning 
The dosimeters were evaluated 45 minutes after irradiation using a Vista Optical CT Scanner 
(Modus Medical Devices Inc.) at a central wavelength of 590 nm. A total of 512 projections 
were collected over 360o and the data was reconstructed with VistaRecon™ software to 




gel phantom with and without the metal valve in place in order to investigate the dosimetric 
inaccuracies caused by missing ray-sum data. 
 
6.2.4 Film Dosimetry 
Equivalent measurements using EBT3 film were made to evaluate the accuracy of the 
developed Fricke gel methodology. To accomplish this, the gel phantoms were recreated 
using the same process outlined above but with a solution of only Gelatin (~300 g Bloom) 
and water. The containers were filled halfway, allowed to set, then pieces of film were 
carefully positioned immediately downstream of the high-density implant. Identical fields 
were delivered to these film phantoms and were evaluated as per the protocol outlined in 
Kairn et. al. [59] and Devic et. al. [121]. Moving point averages were also applied to the film 
profiles to smooth the data. It is expected that doses measured in the Fricke gel phantoms 
near the gel-implant interface can be validated by the doses recorded via conventional film 
dosimetry. 
 
6.3 Results and Discussion 
Fig. 6.3 shows transmission images of the Fricke gel phantom that was irradiated with a 5×5 
cm2 6MV photon field. The tight fit of the suspended metal valve in the cavity is clearly 
indicated in the image below, allowing for accurate dosimetric evaluation within the 
resolution of the scanner. The approximate location of the corresponding reconstructed image 




Figure 6.3 Transmission images of Fricke gel phantom during scanning after being irradiated with 
5×5cm2 6MV photon field. 
 
Fig. 6.4 shows the reconstructed image slices of the irradiated phantom in Fig. 6.3. 
Significant radial streaking is present when the phantom is scanned with the obstruction in 
place. Additionally, as a result of the missing ray-sum data, the apparent size of the 
obstruction is magnified by as much as 15% perpendicular to the direction of the beam, and 
7% parallel to the beam. Cold spots upstream and downstream of the obstruction are also 
present. Evidently, when the metal valve is present during scanning, the prospect of accurate 





         
Figure 6.4 Reconstructed image slices of a Fricke gel phantom after being scanned with (a) and 
without (b) the suspended metal valve. Phantom was irradiated with 5×5cm2 6MV photon field. 
 
 
Figure 6.5 Photon dose profiles 1 mm downstream of the implant obtained from reconstructed image 
slices of Fricke gel phantoms with metal valve and without metal valve during scanning, and from 






       
Figure 6.6 Photon dose profiles 2 mm downstream of the implant obtained from reconstructed image 
slices of Fricke gel phantoms with metal valve and without metal valve during scanning, and from 
EBT3 film. Approximate profile orientations and positions are displayed in Fig. 6.4. 
 
Fig. 6.5 illustrates the downstream dose reduction caused by the high-density implant for the 
same gel phantom that has been reconstructed with and without the suspended metal valve 
during scanning, and for the equivalent dose profile measured using film. The profile 
locations were taken at identical positions across both sets of data and are approximately 
indicated in Fig. 6.4 by the dashed lines. The radial streaking presents itself as fluctuations 
across the high dose regions of the profile. Furthermore, the apparent magnification of the 
obstruction has presented itself as a large increase in the recorded dose at the centre of the 
profile. Cold spots caused by the missing ray-sum data are also evident at profile positions of 
35 mm and 45mm where they overestimate the dose perturbation caused by the high-density 
material. By removing the magnet from the cavity during scanning, the images provide a 
much more accurate dose evaluation with a measured downstream dose reduction of 
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approximately 12%. This differs from the 9% dose reduction recorded by the film. Despite 
this, the film shows good agreement at points further away from the cavity. This discrepancy 
of dose profiles between the film and gel is reduced when profiles are taken at a distance of 2 
mm downstream of the implant as shown in Fig. 6.6. This would suggest that the response of 
the Fricke gel in the 1 mm surrounding the interface is affected by the diffusion of active 
chemicals from the gel to the solution in the cavity, and vice versa. 
 
 
Figure 6.7 Transmission images of Fricke gel phantom during scanning after being irradiated with 
6×6cm2 12MeV electron field. 
 
Transmission images of the 12 MeV electron field delivered to another Fricke gel phantom 
are displayed in Fig. 6.7. The suspended implant was rotated in the gel phantom to more 
accurately represent clinical treatments where electron boost fields delivered in post-
mastectomy radiotherapy are commonly delivered at incidences perpendicular to the metal 
valve. Additionally, this represents a non-circular, off-centre geometry further demonstrating 




         
Figure 6.8 Reconstructed image slices of a Fricke gel phantom after being scanned with (a) and 
without (b) the suspended metal valve. Phantom was irradiated with 6×6 cm2 12 MeV electron field. 
 
In the geometry shown in Fig. 6.8, it is clear that the non-circular shape of the obstruction 
produces more detrimental artefacts. There is a larger area of inaccurate dose information 
immediately surrounding the high-density implant with significant streaking artefacts 
extending to the edge of the container. Cold streaks emanate from the corners of the 
obstruction and hot spots surround the rest of the obstruction, magnifying the detected size of 
the valve. Almost all the artefacts have been effectively eliminated using the implant 
suspension and removal technique, except for the small streaking artefacts stemming from the 
corners of the cavity.	 Increased optical scatter at the corners of the cavity cause these 
streaking artefacts, which cannot be fixed by refractive index matching. While this is a minor 
limitation of the methods scope, it is possible that these artefacts can be avoided by slightly 









Figure 6.9 Electron dose profiles 1 mm downstream of the implant obtained from reconstructed 
image slices of Fricke gel phantoms with metal valve and without metal valve during scanning, and 
from EBT3 film. Approximate profile orientations and positions are displayed in Fig. 6.8. 
 
The downstream dose reduction in the electron boost field caused by the metal valve is 
shown in Fig. 6.9 for the same gel phantom that has been optically scanned with and without 
the suspended obstruction, and for the equivalent dose profile measured using film. The 
profiles locations were taken at identical positions across both sets of data and are 
approximately indicated in Fig. 6.8 by the dashed lines. The cold streaks seen in Fig 6.8 (a) 
present themselves as dose reductions at profile positions 22 mm, and 60 mm. Similarly, 
further streaking artefacts can be seen as fluctuations in the high dose regions, eliminating the 
ability to even resolve dose information far away from the obstruction. Once again, the 
apparent magnification of the obstruction removes the potential for meaningful dose 
evaluation close to the high-density implant, as the profile incorrectly shows massive 
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increases in the distal dose. Clearly, use of the FPB algorithm to reconstruct optical CT image 
slices containing opaque objects can lead to substantial inaccuracies if the effects of missing 
ray-sum data are not taken into account.  
 
Removal of the magnet from the cavity during scanning allows for a smooth dose profile to 
be obtained. In this geometry, an approximate dose reduction of 18% in the 12 MeV electron 
field is recorded at a distance of 1 mm downstream of the implant. The minor streaking had 
no effect on the dose profiles taken downstream of the heterogeneity. Once again, this 
measured dose depletion differs by approximately 3% from the reduction recorded by the 
film despite doses further away from the cavity showing good agreement.             
 
Figure 6.10 Electron dose profiles 2 mm downstream of the implant obtained from reconstructed 
image slices of Fricke gel phantoms with metal valve and without metal valve during scanning, and 
from EBT3 film. Approximate profile orientations and positions are displayed in Fig. 6.8. 
103 
	
This overestimation of the dose perturbation was corrected once more when dose profiles 
were taken at a distance of 2 mm downstream of the implant as seen in Fig. 6.10. Clearly, 
dose measurements within 1 mm of the cavity are subject to slight dosimetric inaccuracies 
due potentially to diffusion of reactants across the interface or increased oxygen exposure 
resulting in a varied sensitivity. Despite this, good agreement is shown between film and gel 
dose profiles at distances greater than 1 mm from the interface. This 1 mm buffer may 
however increase if lengthier times between pre-scanning, irradiation, and post-scanning are 
used. Nevertheless, given the poor spatial stability of Fricke gels, efficient scanning times are 
required if dosimetric accuracy is desired. 
 
6.4 Conclusions 
The methodology developed in this chapter for using Fricke gels in dosimetry surrounding 
high-density implants has dramatically improved on the results in the previous chapter. By 
setting cavities in the Fricke gel phantoms using 3D printed moulds, the placement and 
removal of high-density implants in gel phantoms between irradiation and optical-CT 
scanning becomes simple. This technique was tested on the metal valve extracted from a 
Mentor Temporary Tissue expander in both photon and electron treatments in two 
geometries. Results have shown very good agreement between gel and film dose profiles 
within 2 mm from the surface of the implant. Deviations of approximately 3% between gel 
and film profiles are present within 1 mm of the high-density magnet potentially caused by 
the diffusion of active chemicals at the gel-fluid interface. Nonetheless, artefacts in the form 
of radial streaking, cold spots, and hot spots, were all effectively removed using this 
technique. The only limitation of the technique arises from the use of a non-circular geometry 
where an increase in the optical scatter at sharp corners of the cavity forms some slight 
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streaking. Despite this, for the geometries tested, streaking was limited to dose regions of less 
clinical significance (i.e. not in areas downstream of the implant).  
 
The methods described in this study have the potential to enable the broader and more 
accurate use of optical-CT imaging of gels containing high-density implants. Unlike results 
obtained in the previous chapter, accurate dose information can be obtained as close as 2 mm 
away from the suspended implant, allowing for an examination of interface effects of high-
density materials in radiotherapy beams. However, this methodology is limited to gel 
formulations that are not susceptible to oxygen contamination. In cases where polymer gels 
are used for examining dose distributions surrounding embedded objects, the linear 
interpolation correction outlined in the previous chapter should be used.   
 
In cases where the Fricke gel formulation is used in conjunction with second generation 
optical-CT scanners, it is recommended that cavities be set in the gel phantom rather than the 
application of the linear interpolation correction. Results in this chapter have shown that this 
would allow more accurate dose information to be obtained closer to the suspended implant. 
The methods developed in this chapter can also be applied to improving the dosimetric 
accuracy of gels containing other imbedded objects such as scintillators or brachytherapy 
sources.  
 










Verifying HDR brachytherapy distributions using 
3D Fricke gel dosimeters 
 
7.1 Introduction 
Results from Chapter 6 demonstrated a methodology which minimises artefact production 
when using Fricke gel dosimeters containing obstructions and optical-CT scanning 
techniques. This methodology is able to be adapted and used to investigate the potential for 
3D Fricke gel dosimeters in the verification of high dose rate brachytherapy treatments. This 
work is based on the similar principle of circumventing artifact production induced by 
missing ray-sum data, by removing obstructions during optical-CT imaging.  
 
Fricke gel phantoms which have the ability to accurately and efficiently investigate 
increasingly complex HDR brachytherapy treatments, such as intensity modulated 
brachytherapy which utilises non-isotropic sources, would be a valuable dosimetry tool. Pre-
treatment dose verification is an integral part of patient-specific quality assurance, 
particularly when dealing with high dose rates. This process would ensure that the correct 
source is being used; that the source data has not been modified and correct activity, 
treatment date, and decay are used; and that any bugs in the planning software have not 
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affected the dose calculation. Thus the work in this chapter aims to develop a methodology 
for accurate and efficient pre-treatment brachytherapy dose verification. 
 
7.2 Methods 
7.2.1  Fricke gel phantoms 
The Fricke Xylenol (FX) gel dosimeters used in this study were composed of: gelatin from 
porcine skin of 300 Bloom strength, 50 mM sulfuric acid, 0.2 mM ferrous sulfate (FS), 0.2 
mM xylenol orange (XO), and Milli-Q water [92]. The gel formulation was mixed with a 
magnetic stirrer whilst the heat was maintained at approximately 45 oC. 
 





Fig. 7.1 shows the schematics of both gel phantoms including custom designed and 3D 
printed needle positioners and stabilisers. These were created in SketchUP Make 8 (Trimble 
Navigation Limited, Sunnyvale, California, USA) before being exported as stereolithography 
files and printed on a MakerBot Replicator 2 (MakerBot, Brooklyn, NY) using polyactic acid 
(PLA) filament. Each phantom used 2 mm stainless steel needles that were positioned before 
the gel was poured and allowed to set for 24 hours by refrigeration at approximately 4 oC. In 
the multi-catheter phantom, the four needles were arranged to form a square with a separation 
distance of 20 mm, while the calibration phantom had its needle placed in the central axis. 
 
7.2.2  Brachytherapy irradiation and treatment planning 
Brachytherapy irradiations were performed with a Microselectron high dose rate remote 
afterloading device (Nucletron, Veenendaal, Netherlands). The machine has a 192Ir 
radioactive source which has an active length of 3.6 mm and a diameter of 0.65 mm. At the 




Figure 7.2 Planned dose distributions for the (a) multicatheter phantom, and (b) calibration phantom. 
The 1000 cGy, 800 cGy, 600 cGy, 400 cGy, and 200 cGy isodose lines are shown. 
 
CT data was acquired for each phantom at a slice thickness of 0.5 mm, before being imported 
into the brachytherapy module of the Oncentra treatment planning system (Elekta 
Brachytherapy Solutions, Veenendaal, The Netherlands) where a treatment was planned to 
deliver the doses reported in Fig. 7.2. These dose distributions required 45 dwell positions in 
each catheter with a step size of 0.25 cm and corresponding dwell times of 5.3 seconds for 
the calibration phantom, and 2.1 seconds for each needle in the multi-catheter phantom. After 
placing each phantom in a water tank to ensure backscatter conditions matched the treatment 










7.2.3 Optical Computed Tomography Scanning 
Each phantom was evaluated 50 minutes after irradiation using a Vista Optical CT Scanner 
(Modus Medical Devices Inc.) in conjunction with VistaRecon™ software. The stainless 
steel needles were removed during pre- and post-scanning due to the potential for artefacts 
caused by missing ray-sum data similar to the methodology employed in the previous 
chapter. The cylindrical cavities that remained were filled with refractive index matched fluid 
made up of Glycerol, combined with an identical FX solution without the gelling agent (10 




















7.3 Results and Discussion 
 
 
Figure 7.3 Measured dose profiles (solid lines) vs calculated dose profiles taken from TPS system 
(dotted lines) for distances of (a) 1 mm, (b) 2 mm, (c) 3 mm, (d) 4 mm, (e) 5 mm, and (f) 6 mm away 
from 2 needles. Inset indicates approximate profile positions. 
 
Comparisons of planned and measured dose profiles are shown in Fig. 7.3. There is a 
generally good agreement across all profiles except for the high dose regions present 1 mm 






dose exceeds 800 cGy. This slight deviation can be attributed to the reduced concentrations 
of FS and XO in our gel formulation. With this lower concentration, the range of linear dose 
response is reduced [122], and thus when reaching the higher doses, the gel under responds.  
Alternatively, this local under-response in the 1 mm region surrounding the cavity could also 
be caused by diffusion of reactive species out of the gel during scanning – similar to the 
results obtained in the previous chapter. 
 
Nevertheless, the highest discrepancy outside this high dose region is less than 1%, 
demonstrating the viability of this technique for obtaining dose information to within 1 mm 
of each needle.  Previous studies using normoxic polymer gel dosimeters in conjunction with 
MRI imaging have been shown to produce accurate dose maps to within 2 mm for single 
needle phantoms [86]. The ability to provide accurate dose information to within 1 mm for 
multicatheter brachytherapy treatments using optical scanning techniques and Fricke gel 
dosimeters illustrates the potential for this methodology to be used as a quality assurance tool 
for more complex treatments. 




Figure 7.4 Isodose lines comparing measured dose distributions (left) to treatment planning 
calculations (right) for (a) multiple 2 mm needles, and (b) a 2 mm single needle. 
 
Isodose lines from the measured and calculated dose distributions are displayed in Fig. 7.4. 
Good agreement is shown for the lower doses towards the edge of the container, and the 
steeper doses closer to the treatment needles in both the multi-needle and single needle 
phantoms. Similar results have been shown using NMR imaging and Fricke gel dosimetry for 
brachytherapy source verification [122]. However, the main advantage of using optical-CT 










scanning of these phantoms can be completed in a matter of minutes. The result in Fig. 7.5 
demonstrates this ability to resolve high dose gradients surrounding the needles when the 
outlined optical scanning protocol is used. Additionally, these Fricke gel phantoms can be 
manufactured under normal atmospheric conditions and can be prepared in under an hour for 
irradiation the following day. The ease with which these Fricke gel phantoms can be 
manufactured and used to verify multicatheter dose distributions using optical-CT methods 
demonstrates its viability as a quality assurance tool.   
 






The use of Fricke gel dosimeters in conjunction with optical scanning methods described in 
this work has been shown to produce accurate dose information for multicatheter treatments 
when compared to calculated doses from the brachytherapy module of the Oncentra TPS. It is 
shown that backfilling of catheter cavities with optically matched fluid prior to scanning 
enables accurate optical-CT imaging of the brachytherapy gel dosimeters. With correctly 
matched fluid, multi-catheter treatments can be scanned and reconstructed without generating 
any artefacts induced by missing ray-sum data.  
 
The results have shown that this system is capable of accurately resolving high-dose 
gradients to within 1 mm of each needle in a multi-catheter treatment. This could prove to be 
a powerful dosimetry tool for investigating increasingly complex treatments. Additionally, 
the ease with which these Fricke gel phantoms can be manufactured and used to verify 
multicatheter dose distributions establishes its viability as a quality assurance tool for high 













8.1 Project Outcomes 
This project set out to establish a methodology whereby the effects of high-density implants 
could be quantified accurately and efficiently. A better understanding the impact of high-
density materials on radiotherapy dose distributions enables more accurate treatments to be 
delivered with more confidence, resulting in in improved patient outcomes. 
 
The initial investigation in Chapter 3 quantified the dosimetric effects of the temporary tissue 
expander. Since effective postmastectomy treatments cannot be planned without the beam 
passing through the high-Z material, it was important to establish the effects that this implant 
has on photon and electron beam dose distributions. In this work, conventional dosimetry 
techniques were used to evaluate dose distributions for a variety of different phantoms and 
beam geometries. Using EBT2 radiochromic film, it was shown that the magnetic disk 
present in a tissue expander causes a dose reduction of approximately 20% in a photon 
tangent treatment and 56% in electron boost fields immediately downstream of the implant. 
The effects of the silicon elastomer were also much more apparent in an electron beam than a 
photon beam. This investigation was performed to demonstrate that each component of the 
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tissue expander attenuates the radiation beam to different degrees, with the most significant 
dose perturbation occurring due to attenuation through the magnetic disk. This highlighted 
the importance of accurately modelling materials of high-density and high atomic number in 
order to provide accurate treatment planning dose calculations for postmastectomy 
radiotherapy patients. This work also highlighted the limitations of current dosimetry 
methodologies for efficiently evaluating 3D dose distributions surrounding high-density 
implants. While these film measurements did provide an accurate result and a better 
understanding of the dose perturbations caused by the TTE, its use as a dosimeter in the 
vicinity of high-density materials in general is limited by the 2D nature of the dosimeter as 
well as the inherent uncertainties in film irradiation and processing.  Therefore, this limited 
its usability in achieving the overall objectives of this research project. 
 
Based on the results in the initial investigation, the importance of an accurately modelled 
high-density implant in the treatment planning system was demonstrated. The section of work 
that followed in Chapter 4 used Monte Carlo simulations to evaluate the Pinnacle Treatment 
Planning System’s dose calculations for the high-density magnetic valve in the temporary 
tissue expander. The work demonstrated the importance of an extended CT ramp to 
accommodate for high-Z materials since an override correction was required for accurate 
dose calculations. Results showed that there would be an underestimation of the dose 
perturbation by as much as 5%, if no override correction were applied to the TTE. Therefore, 
it was recommended that a density override correction of 7.4 g/cm3 be applied to the 
magnetic disk to ensure a more accurate dose calculation downstream of the implant. While 
this work demonstrated the potential for an accurate theoretical understanding of 3D 
radiotherapy dose distributions in complex mediums, there remained a need to verify these 
dose distributions via direct measurement.  Radiosensitive gels were considered to be a 
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potential candidate in the measurement of complex 3D dose distributions surrounding high-
density implants. 
 
The subsequent investigation examined potential sources of uncertainty when radiosensitive 
gels are used in dose distribution measurements for implants suspended in the dosimeter. This 
piece of work established the degradation in image quality, and subsequent dose evaluation 
inaccuracies, that are encountered when an optical-CT system reconstructs an image slice of a 
gel dosimeter containing an opaque implant. This is because the filtered back projection 
method, which is employed by optical-CT systems, does not provide a mechanism to deal 
with missing ray-sum data caused by metallic or opaque implants suspended in gels. The 
feasibility of a simple correction method to improve the accuracy of radiotherapy dose 
distribution measurements under these circumstances was also evaluated. This correction was 
shown to significantly improve dose evaluation accuracy close to the suspended implant. 
With careful placement of the implant within the gel sample, and use of the linear 
interpolation method described in this section of work, it was demonstrated that there is the 
potential for more accurate optical CT imaging of gels with immersed high-density implants.  
 
In an effort to improve on the outcomes of Chapter 5, the subsequent investigation developed 
a methodology for using Fricke gel dosimeters for dose distribution measurements 
surrounding high-density implants which completely circumvents artifact production induced 
by missing ray-sum data by removing the obstruction during imaging. Initially, the PAGAT 
gel formulation was investigated for this section of work due to its advantageous spatial 
stability. However, given its susceptibility to oxygen contamination as well as the lengthier 
manufacturing time,	 corrections to polymer gels containing suspended implants are 
essentially limited to the linear interpolation methods described in the previous chapter. 
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Improvements to the results from the previous chapter were investigated using the Fricke gel 
formulation since it is not susceptible to oxygen contamination and the problem of diffusion 
could be negated by scanning within 90 minutes after irradiation. In this work, custom 3D 
printed moulds were used to set cavities in the Fricke gel phantoms to allow for the 
suspension of high density implants in various geometries. This allowed for the metal valve 
extracted from a Temporary Tissue expander to be suspended during irradiation, and 
removed during optical-CT scanning. The removal of the metal implant and subsequent 
backfilling of the remaining cavity with optically matched fluid prior to dose evaluation 
enabled accurate optical-CT scanning of the gel dosimeters. Results showed very good 
agreement between measured and calculated doses within 2 mm from the surface of the 
implant. Slight deviations are present within 1 mm of the interface due to diffusion of 
reactive species across the cavity interface during scanning and irradiation. However, 
artefacts were all effectively removed using this technique enabling the broader and more 
accurate use of optical-CT for the imaging of gels containing high-density implants. The 
ability to obtain accurate dose information within 1 mm of a high-density implant would 
allow for a 3D examination of the interface effects of high-density materials in radiotherapy 
beams. Quantifying dose perturbations and interface effects near metal-tissue interfaces 
provides a more comprehensive understanding of the impact that high-density implants have 
in radiotherapy. Additionally, this methodology could also be used in the validation of 
increasing complex Monte Carlo simulations in complex mediums. 
 
Techniques from the methodology developed in Chapter 6 were able to be adapted to verify 
high dose rate brachytherapy treatments using 3D Fricke gel phantoms. In this investigation, 
a multi-catheter brachytherapy gel phantom was irradiated and the measured doses from 
optical CT scanning were compared to those calculated by the treatment planning system. 
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The removal of the stainless steel needles and subsequent backfilling of these cavities with 
optically matched fluid prior to imaging enabled accurate optical-CT scanning of the gel. 
Results showed very good agreement between measured and calculated doses to within 1 mm 
of each catheter. Additionally, the ease with which these Fricke gel phantoms were 
manufactured and used to verify multicatheter dose distributions established the viability of 
this technique as a quality assurance tool for high dose rate brachytherapy treatments. With 
the development of increasingly complex HDR brachytherapy treatments, such as intensity 
modulated brachytherapy which utilises non-isotropic sources, the need to verify the accuracy 
of such techniques becomes increasingly important demonstrating the value of this developed 
methodology. 
 
The results of this research project have demonstrated the importance of quantifying the 
impact of high-density materials on radiotherapy dose distributions. By developing a 
methodology for accurately and efficiently obtaining 3D dose distribution information in the 
vicinity of high-density implants, the aim of this work has been achieved. 
 
8.2 Further Work 
The potential areas for further investigation into aspects of this work are outlined below: 
§ The pre-reconstruction correction for missing ray-sum data described in Chapter 5 
was shown to significantly improve dose evaluation accuracy close to the suspended 
implant. However, there are more labour intensive methods (which have been 
proposed in x-ray CT to reduce metal artefacts), such as iterative reconstructions, that 
could be investigated to further improve on this result. 
§ Independent Monte Carlo calculations and supplementary measurements could be 
made to corroborate results of the techniques developed in Chapter 7 
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since understanding dosimetry near interfaces is a complex issue given the high dose 
and chemical gradients. 
§ Investigation of increasingly complex brachytherapy treatments using the 
methodology described in chapter 8 would further establish this technique as a 
powerful dosimetry tool. 
 
8.3 Summary 
While the initial investigation of this work established the effects of the temporary tissue 
expander on photon and electron beam dose distributions, the combined results of the 
subsequent studies go beyond simply evaluating the dosimetric effects of a specific clinical 
implant. The methodologies described in this work allow for the dosimetric effects of any 
particular object to be verified via: 
1) Film measurements; which have been shown to provide accurate dose information 
close to high-density materials both in this thesis, and in the literature, and is limited 
only by its 2D nature. 
2) Monte Carlo simulations; which have been shown to accurately calculate 3D dose 
distributions surrounding high-density implants, provided that appropriate densities 
are used during simulations. 
3) Gel dosimeters susceptible to oxygen contamination; which is achieved by applying 
the linear interpolation correction described in Chapter 5. The application of this 
correction to gels containing irremovable embedded objects was shown to 
dramatically improve the achievable measurement accuracy of optical CT readout in 
the presence of opaque objects.  
4) Gel dosimeters which are not susceptible to oxygen contamination; which allows for 
the suspension of the implant during irradiation and removal during imaging. This 
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method was shown to improve the dosimetric evaluation accuracy of gels containing 
implants, as well as brachytherapy sources. 
Each of these described methods has the potential to allow for more accurate and efficient 
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This work examined the suitability of the PAGAT gel dosimeter for use in dose distribution 
measurements around high-density implants. An assessment of the gels reactivity with 
various metals was performed and no corrosive effects were observed. An artefact reduction 
technique was also investigated in order to minimise scattering of the laser light in the optical 
CT scans. The potential for attenuation and backscatter measurements using this gel 
dosimeter were examined for a temporary tissue expander’s internal magnetic port. 
1. Introduction 
The success or failure of radiation therapy treatments is largely dependent on the ability to 
deliver the prescribed dose to the patient within a narrow tolerance. However, the human 
body consists of many components that vary in density which have been shown to cause 
complications in treatment planning and hence delivery [1, 2]. These can include naturally 
occurring internal inhomogeneities, as well as man-made biomaterials such as implants and 
prostheses. While these may be necessary for the survival or quality of life of radiotherapy 
patients, they also have the potential to seriously compromise the accuracy of radiotherapy 
treatment planning, and hence delivery. This work examines the feasibility of using the 
PAGAT gel dosimeter for dose distribution measurements around high-density implants.  
 
Gel dosimeters have the capacity to record radiation dose distributions in three-dimensions 
(3D) making them a very promising dosimetric tool for external beam radiotherapy [3]. It has 
been shown that the PAGAT gel formulation is approximately radiologically water 
equivalent for electron and photon beams [4] and is therefore an ideal 3D dosimeter for 
studying the effects of implants on patient dosimetry. The main advantage of using a gel 
dosimeter for this work is that complex shaped implants can be investigated due to their 
complete immersion in the gel thus alleviating the requirement of simplified geometry. Using 
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PAGAT gel also means the conditions of the implant placement in the patient are matched. 
Here we present an examination of the suitability of using PAGAT gel dosimeters for dose 




2.1 System optimisation 
Before the PAGAT gel dosimeter was used for dose distribution measurements around high-
density implants, an assessment of the reactivity with various metals was performed. Objects 
composed of stainless steel, brass, and zinc were suspended in the mixture and observed over 
a period of 7 days to examine any potential corrosive effects. An artefact reduction technique 
was also investigated whereby metal objects suspended in the gel formulation were imaged in 
the optical CT scanner with, and without a coat of black paint to determine the extent of 
scattering of the laser light in the imaging system. 
 
2.2 Manufacturing the PAGAT gel 
As per the recipe recommended by Venning et. al. [5] and Khoei et. al. [6], the PAGAT 
polymer gel formulation by % mass consisted of 4.5% N,N'-methylenbis-acrylamide (bis), 
4.5% acrylamide (AA), 5% gelatine, 7 mM tetrakis (hydroxymethyl) phosphonium chloride 
(THPC), 0.01 mM hydroquinone (HQ) and 86% HPLC (Water). When the preparation of the 
final polymer gel solution was completed, it was transferred into phantom along with the 






2.3 Gel Irradiation 
The internal magnetic port (IMP) of a Mentor temporary tissue expander was extracted from 
the implant and suspended in a container of gel. The magnetic disk (1.5cm diameter, 0.5cm 
thickness) allows the position of the valve inside the patient’s body to be determined. 
However, this IMP is composed of a high-density neodymium magnet cased in titanium, 
which has the potential to compromise the accuracy of radiotherapy treatment planning, 
illustrating the need for 3D dose distribution measurements. The gel container was irradiated 
with a 5x5cm2, 6MV photon beam from a Varian 21iX Clinac. The post-manufacturing time 
was selected to be 24 hours. 
 
2.4 Imaging 
The container was imaged in a MGS Research IQScan optical CT scanner specifically 
designed for readout of irradiated gel dosimeters. The imaging parameters included a field of 
view (FOV) of 220mm, 720 projections, a 360o rotation range, allowing a resolution of 
0.5mm pixels. This pre- and post-scan data was reconstructed using filtered-back projection 
to create a 3D model of the dose distribution surrounding the high-density implant. 
 
3. Results and Discussion 
The results displayed in figure 1 demonstrate that the application of a non-reflective coating 
to the suspended metallic object has substantially reduced imaging artefacts in the optical CT 
scanner. Additionally, no corrosive effects were observed for the various metal objects that 
were submerged in the PAGAT gel formulation.   




Figure A.1 Image slices of stainless steel bolt uncoated (left) and coated (right) with black 
paint submerged in PAGAT gel. These were obtained using the optical CT scanner at a 
resolution of 1 mm. 
 
The radiation-induced polymerisation of the PAGAT gel formulation displayed in figure 2 
shows a visible dose depletion downstream of the magnetic disk. However, the suspension 
angle of the internal magnetic port prevented the optical CT scanner from detecting the 
underdosed region. This issue is resolved by simply implementing a horizontal, and therefore 
symmetrical, suspension method for the implant which allows the scanning laser to traverse 





           
Figure A.2 An example treatment being delivered to the gel container is shown (left) 
alongside a photo of the PAGAT gel container with the suspended internal magnetic port 
post-irradiation (right). 
 
Figure 3 shows a single reconstructed slice produced by the optical CT scanner with a 
resolution of 0.5mm. Also included is a normalised profile of the slice; thus employing 
internal calibration for optimal dose to gel [7]. This image slice illustrates that dose 
measurements in the proximity of the container wall are susceptible to edge artefacts and 
therefore should be avoided. Similarly, the cylindrical shape of the metallic implant makes it 
difficult to discern whether the profile peaks visible in figure 3 are the result of the 
production of secondary particles in the metal causing increased polymerisation, or more 




          
Figure A.3 Optical CT image slice of gel container with 0.5mm resolution with an indicator 
of profile location and beam direction (left) with corresponding profile plot (right). 
 
Despite the absence of qualitative data regarding attenuation effects of the implant, this study 
demonstrated the viability of using the PAGAT gel dosimeter for attenuation and backscatter 
measurements of a temporary tissue expander’s internal magnetic port. 
 
4. Conclusions 
The suitability of the PAGAT gel dosimeter for use in dose distribution measurements around 
high-density implants was evaluated. This work demonstrated the potential that with an 
optimized gel dosimetry system, various implants can be placed into phantoms and followed 
through the clinical scenario of CT scanning, treatment planning, irradiation, and evaluation.  
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